Browse by Track

Type here to filter the list

Bioanalytics
W1230-12-79 - A Faster Method for Relative Quantification of N-glycans for Therapeutic Monoclonal Antibody during Trastuzumab Biosimilar Development

Favorite
M1530-11-72 - A Fully Validated LC-MS/MS Method for Quantitation of Oxybenzone in Serum

Favorite
T1030-11-71 - A Novel Blood-Based Biomarker Distinguishes Estrogen-Negative Solid Tumors in Patient Samples

Favorite
W1030-11-72 - A Robust and Specific LC-MS/MS Method for the Measurement of Cortisol as a Biomarker in Human Serum for Clinical Studies

Favorite
M0930-11-71 - A Sensitive and Selective UPLC-MS/MS Method for Simultaneous Determination of Paclitaxel, Gemcitabine, and Carboplatin in Human Plasma and Animal Tissues

Favorite
T1230-11-73 - A Sensitive ELISA Method for the Quantification of Anti-PD-1 Antibody Drug in Human Serum

Favorite
M1530-11-73 - A Sensitive Quantification of Unbound Vemurafenib in Human Plasma Using Equilibrium Dialysis Followed By Ultra-performance Liquid Chromatography Coupled to a Tandem Mass Spectrometry

Favorite
M0930-12-78 - Activatable Core–Shell Metallofullerene Nanoprobes for High Relaxivity Magnetic Resonance/Fluorescence Bimodal Imaging of Glutathione

Favorite
M1430-11-76 - Assay Acceptance and Reporting Criteria of the Dendritic Cell Activation Assay Contributing to the Assessment of Innate Immunogenicity Risk

Favorite
T1230-12-80 - Assay and Identification of a Growth Media Containing 4 Amino Acids by a Novel HPLC Method with Charged Aerosol Detection

Favorite
W0930-12-78 - Assay Development Kit - Rapid Reagent Pair Screening and Optimization for Ligand-Binding Assays

Favorite
T1330-11-73 - Assay Performance Evaluation of Simple Plex^TM Cartridge-Based ELLA and DuoSet ELISA Assay for the Detection of B-cell Maturation Antigen (BCMA) Biomarker

Favorite
W0930-11-71 - Assessment of Chemical Reactivity of BTK Covalent Inhibitors by a Simple Reaction Assay with GSH

Favorite
T1130-11-73 - Assessment of Pre-Existing Anti-Drug Antibodies Against Novel Nanobody Therapeutic

Favorite
M1330-12-77 - Bioanalytical and Logistical Considerations in Patient Centric Volumetric Absorptive Microsampling

Favorite
W1130-11-71 - Biodistribution of TAT or QLPVM Coupled to Receptor Targeted Liposomes for Delivery of Anticancer Therapeutics to Brain In Vitro and In Vivo

Favorite
T1430-11-73 - Bullfrog oil (Rana catesbeiana Shaw) Induces Apoptosis in A2058 Human Melanoma Cells by Mitochondrial Dysfunction Triggered by Oxidative Stress

Favorite
T1130-12-80 - Cancer Stem Cells and Tyrosine Kinase Receptors Directed Non-Lipid Based Nanoparticles for Pancreatic Ductal Adenocarcinoma Imaging and Therapy

Favorite
W1230-12-77 - Capillary Microsampling Combined with a Microfluidic Immunoassay Technology Provides a Reliable and Robust Method to Measure Therapeutic Antibodies and Their Targets in Preclinical Studies

Favorite
T1130-11-74 - Case Study to Demonstrate Sensitivity in Immunogenicity Assay Should be Based on Result of Both Screening and Confirmatory Tier

Favorite
M1330-11-71 - Cell Wall Metabolite Levels in S. aureus as a Function of Growth Phase

Favorite
T1030-12-80 - Characterization of a Cysteine-conjugated ADC on a Hybrid Quadrupole-Orbitrap Mass Spectrometer

Favorite
T1230-12-81 - Confident and Efficient Characterization of Recombinant Human Follicle Stimulating Hormone with the Q Exactive HF-X BioPharma Platform

Favorite
M1030-12-79 - CTLA4 Immunoassay Validation and Application to Disease Sample Analysis

Favorite
W1130-11-72 - Detection of Dry-Eye Biomarkers in Pooled Human Tears Using Hydrogel-Coated Gold Nanoshells

Favorite
T0930-11-72 - Determination of Total and Free Melphalan Concentrations in Human Plasma Using LC-Tandem Mass Spectrometry

Favorite
T1530-11-74 - Determination of Unbound Piperaquine in Human Plasma

Favorite
T1530-12-77 - Development and Characterization of GLP-1 Total and Active V-PLEX^® Assays

Favorite
T1030-11-72 - Development and Characterization of Human and Rodent Metabolic Assays on the U-PLEX® Platform

Favorite
M1230-11-71 - Development and Characterization of LDV-Peptide Targeted Nanocarriers for Paclitaxel Delivery: A Comparative Study of Micelles, Liposomes and Solid Lipid Nanoparticles

Favorite
M1030-12-77 - Development and Implementation of a Flow Cytometry Assay to Measure Receptor Occupancy of an Anti-CD73 Antibody to Target in a Clinical Trial

Favorite
W1030-11-71 - Development and Implementation of the S-PLEX^® Platform for Converting Standard Immunoassays to High-Sensitivity Assays

Favorite
T1330-12-77 - Development and Validation of a Human Total Soluble TIM-3 Biomarker Assay for Use in Clinical Studies

Favorite
M0930-11-74 - Development and Validation of a LC-MS/MS Method for Simultaneous Measurement of Tanespimycin and Its Active Metabolite (17-AG) in Human Plasma

Favorite
T1430-12-80 - Development and Validation of a Liquid Chromatography Tandem Mass Spectrometry Method as per ICH Guidelines for Quantification of LXR Agonist GW3965 in Mouse Plasma

Favorite
W1130-12-79 - Development and Validation of a New LC-MS/MS Method for Measuring Transmucosal Delivery of Mycophenolate In Vivo

Favorite
T1530-11-71 - Development and Validation of a New LC-MS/MS Method for Measuring Transmucosal Delivery of Oxaliplatin In Vivo

Favorite
M1530-12-82 - Development and Validation of a Quantitative Method for Fulvestrant in Rat Plasma by LC-MS/MS

Favorite
M0930-11-73 - Development and Validation of a Sensitive UPLC-MS/MS Method for Simultaneous Determination of Polydatin and Resveratrol in Plasma: Application to Pharmacokinetic Study

Favorite
T1330-11-72 - Development and Validation of an LC-MS/MS Method for the Simultaneous Quantitation of Fifteen Bile Acids in Human Serum

Favorite
W1130-12-77 - Development and Validation of LC-MS/MS Methods for the Quantitation of Commonly Co-administered Drugs and in Support of Several Clinical Studies

Favorite
M1430-11-74 - Development of a Neutralizing Antibody Assay with Improved Drug Tolerance for an Investigational Antibody by Applying Drug Depletion to Serum Samples

Favorite
M1430-11-73 - Development of a Novel Cell-Based Assay for the Detection of Neutralizing Antibodies to PF-06730512

Favorite
W1030-12-78 - Development of a Novel U-PLEX Method to Differentiate Between Anti-drug Antibody and Target Signals

Favorite
M1530-12-78 - Development of a Sensitive LC-MS/MS-Based Method for the Simultaneous Use of Mannitol and Sucrose as Markers of Blood-Brain Barrier Integrity

Favorite
M1530-12-81 - Development of a Simple and Robust Tryptic Digestion Method for the Determination of Therapeutic Antibodies by LC/MS

Favorite
T1430-12-78 - Development of an Intestinal Tissue Bioanalytical Assay Method for Quantitation of an Antiviral Drug Active Metabolite (CMX521-PPP) and its use in a Pre-Clinical in vivo Analyte Localization Analysis

Favorite
W1130-12-78 - Development of Highly Sensitive (4 pg/mL LOQ) HPLC-MS/MS Bioanalytical Method to Support Clinical Studies of an Inhaled Compound

Favorite
M1330-11-73 - Distribution and Recovery of Human Neonatal Fc Receptor (FcRn) in Sucrose Gradient Fractions from Human Liver Tissues using Multiple Reaction Monitoring (MRM)-based Targeted Proteomic Methods

Favorite
M1330-12-79 - Driving Effectiveness of the Analytical Method Lifecycle with Ruggedness Studies

Favorite
W1230-11-72 - Drug Delivery Using Biocompatible Polymer Encapsulated Magnetic Nanocarriers (PE-MNCs) Enhances Neurite Outgrowth on Inhibitory Substrate

Favorite
T1130-12-79 - Dual Functionalized Liposomes for Efficient Co-delivery of Anti-cancer Chemotherapeutics for the Treatment of Glioblastoma

Favorite
W1130-12-80 - Effect of Rumex acetosa Extract on P-gp and OATP1A2

Favorite
M1030-11-74 - Effect of Freeze Thaw Cycles of Conjugated Reagents on Immunogenicity Assays

Favorite
M1330-11-76 - Effect of Vancomycin on Cytoplasmic Peptidoglycan Intermediate Levels in Vancomycin Resistant Enterococci

Favorite
T1130-12-78 - Effective Formulation of Antioxidant Natural Compound to Polymeric Nanosuspension Shows Better Tumor Regression and Survival

Favorite
T1330-12-79 - Enantiomeric Purity Analysis for Solid Phase Synthesized Peptide Active Pharmaceutical Ingredients

Favorite
T1230-11-72 - Evaluation of an Acid-Treatment Procedure on the Interference of Anti-Drug Antibodies in a Pharmacokinetic Assay

Favorite
T1330-11-74 - Extracellular Vesicles Derived from Brain Endothelial Cells for DNA Delivery

Favorite
W0930-12-77 - Fit-for-Purpose Immunoassay Development for PEG Using DoE and Multiple Platforms

Favorite
M1130-12-79 - Fit-for-Purpose Method Validation of Clinical Biomarker Assays to Show Proof of Biology with Automated Western Blot Technologies

Favorite
M1030-11-73 - Gene Therapy: Strategies to Generate Critical Reagents to Support Assay Development

Favorite
T1430-12-77 - Generation of High-Resolution Metabolite Profiles by HPLC+AMS

Favorite
T0930-12-77 - Generic Method for Quantitation of Human Fc-Fusion Proteins in Mouse Plasma Using BLI Technology

Favorite
T1530-11-73 - High-Performance Liquid Chromatography Method Development and Validation for the Determination of Celastrol in Rat Plasma

Favorite
M1430-11-71 - High-Throughput In Vitro Assays for Immunogenicity Predictions and Risk Assessment

Favorite
M1330-11-75 - Identification of Asparagine Enantiomers and Their Hydrates by Terahertz Time-Domain Spectroscopy

Favorite
T1230-12-77 - Identifications of MabSelect SuRe LX Sepharose Resin and 15 Other Resin Analytes

Favorite
M1130-11-74 - Immune Checkpoint Inhibitor Antibody Drug Conjugate for Chemotherapy Guided Immunotherapy of Solid Tumors

Favorite
M1130-11-71 - Improving the Encapsulation of Gedatolisib, a Weakly Hydrophobic Drug with Limited Aqueous and Non-aqueous Solubility, in Polymeric Nanoparticles via Flash Nanoprecipitation

Favorite
M1030-11-71 - In Vitro Assessment of Immunogenicity for an Exploratory Gonorrhea Vaccine

Favorite
T1430-11-71 - Influence of Penetration Enhancers on Drug Deposition in Different Skin Layers Using Exercised Human Cadaver Skin

Favorite
T1330-12-78 - Laser Microdissection-LC-MS/MS Method for Quantitative Tissue Distribution Analysis (QTDA) of Tumor Tissue

Favorite
T0930-12-78 - LC-MS Method Development for Quantitation of Midazolam, Ketamine and Their Metabolites: Application to a Pharmacokinetic Study in Patients on Extracorporeal Membrane Oxygenation Therapy

Favorite
T1030-11-73 - LC-MS/MS Method for Quantification of Orexin-A in Plasma, a Biomarker for Narcolepsy

Favorite
T0930-11-71 - LC-MS/MS Quantification of Polypeptide ACTH in Human Plasma for Pharmacokinetic (PK) and Toxicokinetic (TK) Studies

Favorite
M1230-11-74 - Lipid Nanoformulations of Vancomycin and Cefazolin in Methicillin-Resistant Staphylococcus aureus Superbug Infection: A Perspective on Efficacy and Uptake

Favorite
W1130-11-73 - Lipid Nanoparticle for Active Targeted Delivery of Vancomycin in MRSA Infection

Favorite
T1530-11-72 - Lower Exposure of Simvastatin and Its Active Metabolite in NAFLD Rat Caused by Lower Intestinal Absorption and Higher Biliary Excretion

Favorite
W0930-12-79 - Magnetic Biosensors for Characterizing Protein-Protein Interactions in Complex Biological Matrix

Favorite
M0930-12-77 - Modernization of Insulin Bioidentity Testing with In-Cell Western Technology

Favorite
T1230-12-78 - MSD and Ella Multiplex Assay Development of IFN-γ, CCL8 and CXCL10

Favorite
T1230-11-71 - MSD GOLD™ Streptavidin and Small Spot Streptavidin Plates: Multi-year Reproducibility and Application to Pharmacokinetic Assay Development

Favorite
M1430-12-79 - Neurofilament Light (NfL) is a Bona-fide Blood Based Biomarker for Neurodegenerative Diseases

Favorite
W1230-12-78 - New Bio-compatible Physiological Bicarbonate Buffer System for Dissolution Testing

Favorite
W1230-11-73 - Novel Elvitegravir Nanoformulation for Drug Delivery Across the Blood-Brain Barrier to Achieve HIV-1 Suppression in the CNS

Favorite
T1330-11-71 - Optimization of a Commercial ELISA to Measure Serum -Defensin 2 in Patients with Psoriasis

Favorite
M1130-11-72 - Optimization of Solid Lipid Nanoparticles to Deliver Efavirenz to Brain for Treatment of Neuro-AIDS

Favorite
T1430-12-79 - Overcoming Stability Issues in the Development of an LC-MS/MS Method for the Quantitation of Azacitidine in Human Plasma

Favorite
W1030-12-80 - PandA Optimization Strategy: Keys to Producing Meaningful Immunogenicity Data and Avoiding the Pitfalls of this Highly Drug Tolerant Format

Favorite
M1130-11-73 - PD-1 siRNA-Solid Lipid Nanoparticles Inhibit Tumor Growth

Favorite
T1230-11-74 - PEGylation Affects the Pharmacokinetic Assessment of Pegfilgrastim Using Ligand Binding Assays

Favorite
M1430-12-78 - Pharmacokinetic and Pharmacodynamic Herb-Drug Interactions between Simvastatin and Gardenia Jasminoids in Healthy and NAFLD Rats

Favorite
M1530-11-71 - Pharmacokinetics of Novel Organic Carbon Monoxide Prodrugs BW-CO-115 and BW-CO-203 via Oral Administration

Favorite
T1230-12-82 - Photoacoustic Nano-Diagnostics of Solid Tumors

Favorite
T0930-11-73 - PK Assay Variability Linked to Plate Positional Effects on MSD Plate Reader

Favorite
M1130-12-78 - Platform Comparisons for Measurement of CCL18: ELISA, IMPACT, and ELLA

Favorite
T1130-11-72 - Pre-existing Antibodies to Biotherapeutics: Two Case Studies for Immunogenicity Assay Design and Appropriate Cut Point Determinations

Favorite
M1030-12-78 - Profiling the Promoter Activity of Different L1 Families in the Mouse Genome to Build an Endogenous Animal Model for Drug Screening

Favorite
W1030-12-79 - Qualification of a Drug-Tolerant Anti-Drug Antibody Assay for C1 Inhibitor in Human Serum

Favorite
M1130-11-75 - Quantification of Chimeric Antigen Receptor T Cells in Blood with a Novel Quantitative PCR Methodology-Recommendation of the Use of the Volume-Based Unit (copies/μL) for the Cellular Kinetic Studies

Favorite
T1530-12-78 - Quantification of Dehydroepiandrosterone (DHEA), 17α-hydroxyprogesterone (17-OHP) and 17α-hydroxypregnenolone (17-OHPreg) in Human Serum Using AB Sciex Triple Quad 5500 LC MS/MS System

Favorite
T1030-12-77 - Quantitation of Biotherapeutics via LCMS - Surrogate Peptide versus Intact Mass Analysis

Favorite
T1030-12-82 - Quantitation of IgG in Human Serum with LC-MS/MS Bottom-Up Strategy

Favorite
M1130-12-77 - Quantitation of Myostatin/GDF8 in Human Serum Using an Enzyme Linked Immunosorbent Assay (ELISA)

Favorite
M1530-12-77 - Quantitation of siRNA and Its Metabolites in RNA-Induced Silencing Complex in Rat Liver Using Immunoprecipitation LC-MS/MS (IP-LC-MS/MS)

Favorite
T1130-11-71 - Rapid In-House Determination of Cut Point Values for Immunogenicity Assays Using JMP and Excel

Favorite
W1030-12-81 - Re-validation of an Immunogenicity Method Following the Issuance of the Finalized FDA Guidance and Assessing the Impact on Clinical Data Interpretations

Favorite
T1230-12-79 - Robust Chemometric Analyses of 2D-NMR Methyl Fingerprints for mAb Therapeutics

Favorite
M1430-11-72 - Screening for Pre-existing Neutralizing Antibodies against AAV Serotypes 1, 2, 5, 6, 8 and 9 In Sera of Different Strains of Pigs

Favorite
W1030-11-74 - Serological Prevalence of Toxoplasmosis in Pregnant Women in Luanda (Angola): Diagnosis of Toxoplasma gondii on Placental Fragments by Nested-PCR

Favorite
M0930-11-72 - Simultaneous Detection and Quantification of Lapatinib and Capecitabine in Plasma and Tissue Using a Sensitive Liquid Chromatography-Tandem Mass Spectrometry Method

Favorite
M1530-12-80 - Simultaneous Determination of Coproporphyrin-I and Coproporphyrin-III in Human Plasms and Human Urine Using LC-MS/MS

Favorite
M1530-11-74 - Simultaneous Quantitative Analysis of Anti-infectious Disease Drug Classes in Human Plasma by LC-MS/MS

Favorite
T1130-12-77 - Spectral Investigation into Qualitative Evaluation of Interaction between Doxorubicin Hydrochloride Entrapped within Poly(butyl)cyanoacrylate Nanoparticles

Favorite
W0930-11-72 - Stability Testing of Compounded Enoxaparin Sodium Injection in Pre-filled Syringesby Using HPLC Isocratic Method

Favorite
W1030-12-82 - Standardized and Efficient Modular Automation of a DOE Driven Method Development of a Solution Phase Bridging ELISA Assay to Support Immunogenicity Assessment

Favorite
W1030-12-77 - Strategies for Overcoming Drug Target Interference in Anti-Pembrolizumab Antibody Detection

Favorite
M0930-12-79 - Streamlined Impurity Analysis Using High Throughput Analytical Automation to Support Process Development and Characterisation Studies

Favorite
W1030-11-73 - Systematic Assay Screening for Specific Biomarker Analysis: Circumvent Antibody Bias

Favorite
T1430-11-72 - The Application of Light-Absorbing Photostabilizers for the Determination of Protoporphyrin IX in Human Plasma by LC-MS/MS

Favorite
M1230-11-73 - The Induction of Effective Cancer Immune Response by the Combination of Lipid Based Bubbles and Therapeutic Ultrasound

Favorite
T1030-12-78 - The Relationship between Selectivity and Drug Delivery Efficiency of Peptide-Drug Conjugate: A Comparison of Three EGFR-Targeting Peptide-Drug Conjugates with Different Affinities

Favorite
M1430-12-77 - Tracing Drug Induced Liver Injury (DILI) signatures by Harnessing Cancer Cell Lines

Favorite
T0930-12-79 - Turning a Negative to a Positive with Anti-metatype Affimer Reagents

Favorite
M1530-12-79 - Ultrasensitive Bioassay for Detection of a TNFα-Specific Antibody in Mouse Samples from Rectal vs IV Administration

Favorite
T1530-12-79 - Ultra-sensitive Immunoassay Characterization using Endogenous Validation Samples.Ultra-sensitive Immunoassay Characterization using Endogenous Validation Samples

Favorite
M1030-11-72 - Using Monosaccharide Peptide/Protein Conjugates as Surrogates to Better Understand Protein-Polysaccharide Conjugate Vaccine Structures

Favorite
M1430-11-75 - Validation of a cell lysate based assay to detect antibodies against CFTR

Favorite
T1030-12-81 - Validation of Multiple LC-MS/MS Methods for Quantification of Bevacizumab and Ranibizumab in Human Plasma after Intravitreal Administration

Favorite
M1230-12-77 - Validation of Quantitative Ligand Binding Assay Using Mouse Serial Sampling

Favorite
Clinical Pharmacology
W1130-13-87 - A Clinical Study Design to Evaluate Whether the Systemic Bioavailability of Topical Drugs may Influence the Assessment of Local Dermal Pharmacokinetics by Dermal Open Flow Microperfusion (dOFM)

Favorite
T1430-13-83 - A Drug-Drug Interaction Study to Study the Effects of Multiple Doses of the CYP3A4 Modulators Itraconazole and Rifampin on the Single Dose Pharmacokinetics of Vatiquinone

Favorite
T0930-13-88 - A Drug-Drug Interaction Study: The Effect of Multiple Doses of Vatiquinone on the Single Dose Pharmacokinetics of Tolbutamide and Omeprazole

Favorite
W1030-13-83 - A Modeling Approach to Predict the Outcome of a Bioequivalence Study: Application to a Triple Combination Tablet of Amlodipine/Irbesartan/Hydrochlorothiazide

Favorite
T1330-13-85 - A Multiscale Mathematical Model to Study Nanomedicine Delivery in Solid Tumors

Favorite
M1530-13-85 - A Pharmacokinetic Study of Two Oxybutynin Transdermal Formulations with Transient Heat Exposure

Favorite
M1130-13-89 - A Population PK-PD Model to Characterize the Increase in Gastrointestinal Motility by YH12852, a Highly Selective 5-HT4 Receptor Agonist, in Healthy Subjects and Patients with Functional Constipation

Favorite
M1030-13-85 - A Retrospective Investigation of Bioanalytical Issues in Pharmacodynamic (PD) Studies Submitted in Abbreviated New Drug Applications (ANDAs) for Low Molecular Weight Heparin (LMWH) Drug Products

Favorite
T1330-13-88 - A Target-Mediated Drug Disposition Population Pharmacokinetic Model of GC1118, a Novel Anti-epidermal Growth Factor Receptor Antibody, in Patients with Refractory Solid Tumors

Favorite
T1130-13-86 - Anti-inflammatory Effect oF Selective CB2 Inverse Agonists in Murine and Human Microglial Cells

Favorite
T1130-13-83 - Application of Delay Differential Equations in Modeling Absorption Problems Related to Irbesartan Pharmacokinetics

Favorite
M1030-13-84 - Application of Physiologically-Based Pharmacokinetic Absorption Modeling and Simulations: Risk Assessment and Control of Critical Quality Attributes for Medical Countermeasure Drug Products

Favorite
T1030-13-87 - Applications and Benefits of Healthy Volunteer Trials to Accelerate Oncology Drug Development

Favorite
T1130-13-87 - Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interaction Potential of Vemurafenib In Vitro in the Presence of Protein Binding and Using Static and Physiologically-Based Pharmacokinetic Models

Favorite
M1330-13-84 - Assessment of Target Inhibition Using a Pharmacokinetic/Pharmacodynamic Model following Intravitreal Administration of an Anti-HtrA1 Antigen-Binding Fragment in a Phase I Study

Favorite
W0930-13-84 - Assessment of the Impact of Drug Dissolution on Pharmacokinetics of Diltiazem Extended Release Drug Products Using Physiologically Based Pharmacokinetic Analysis

Favorite
W0930-13-88 - Biopharmaceutic In Vitro In Vivo Extrapolation (IVIV_E) Informed PBPK Model of Ritonavir Norvir^® Tablet Absorption in Humans Under Fasted and Fed State Conditions

Favorite
M1430-13-86 - Biopharmaceutical Profile, Bioavailability, Food Effect, and Pharmacokinetics of Vericiguat: A Novel Soluble Guanylate Cyclase Stimulator

Favorite
M1530-13-86 - Brain Metabolism of cis- and trans-Permethrin

Favorite
T0930-13-86 - Buffer Capacity of Topical Products: In Vitro and In Vivo Proof and Clinical Significance

Favorite
T0930-13-83 - Circulating Endothelial Cells (CECs) as a Diagnostic and Prognostic Marker for Pulmonary Arterial Hypertension (PAH): A Proof of Concept Study in PAH Patients

Favorite
M1130-13-87 - Comparing the Performance of First-Order Conditional Estimation (FOCE) and Different Expectation-Maximization (EM) Methods in Handling Complex Nonlinear Parent-Metabolite Pharmacokinetic Model

Favorite
W1230-13-84 - Comparison of Three Topical Drug Permeation Enhancers in Human Cadaver Skin Using Conventional Franz Cell Permeation and Mass Spectrometry Imaging

Favorite
T1530-13-87 - Compartmental Pharmacokinetic Model Analysis of Vincristine and Its M1 Metabolite in Kenyan Pediatric Cancer Patients

Favorite
T1530-13-89 - Consistent Lung Delivery of Inhaled Triple ICS/LAMA/LABA Fixed-Dose Combination Using Co-suspension Delivery Technology: An In Silico Modeling Study

Favorite
W1130-13-84 - Dermatopharmacokinetic Assessment of Bio(in)equivalence of Topical Metronidazole Creams Using Tape Stripping

Favorite
T1230-13-87 - Design, Synthesis and Biological Screening of Novel Quinazoline and Pyrrolotriazine Derivatives as Potent HER-2 and VEGFR2 Inhibitors

Favorite
M1030-13-88 - Developing a Physiologically Based Pharmacokinetic Module of Sofosbuvir to Predict a Pediatric Population Dose Using Simcyp Simulator

Favorite
T1330-13-84 - Development and Verification of a Physiologically Based Pharmacokinetic – Pharmacodynamic (PBPK-PD) Canine Model for Propofol in Greyhounds and Beagles

Favorite
T1330-13-87 - Development of a PBPK Model for the Prediction of Amiodarone Pharmacokinetics in Fed and Fasted State Using the Advanced Dissolution, Absorption and Metabolism (ADAM) Model

Favorite
M1030-13-89 - Development of a Physiologically Based Pharmacokinetic (PBPK) Model for Intra-articular Delivery

Favorite
W0930-13-87 - Development of Pharmacokinetic Evaluation System for Effective Formulation Design (X): The Study of the Gastrointestinal Behavior under Dosing OD Tablets without Water by Using GastroPlus^TM

Favorite
M1530-13-87 - Development of Pharmacokinetic Evaluation System for Effective Formulation Design for Generic Medicines: Prediction of Drug Absorption from OD Tablets Containing Poorly Water-Soluble Drugs in Human

Favorite
M0930-13-84 - Differential Genome-Wide H3K9 Acetylation Changes Induced by DNA Hypomethylating Agents

Favorite
T1230-13-86 - Differential Packaging of Cytokines/Chemokines in Macrophages-Derived Exosomes upon Exposures to Tobacco and HIV: Potential Role of These Exosomes in Smoking-Induced HIV Pathogenesis

Favorite
M1430-13-87 - Efavirenz Physiologically Based Pharmacokinetic Model Development and Validation as a Moderate CYP3A4 Inducer for Drug-Drug Interaction Predictions

Favorite
M1530-13-83 - Effect of Food on the Pharmacokinetics of Monomethyl Fumarate After Administration of Diroximel Fumarate

Favorite
M1230-13-84 - Efficacy of Millets as Adjuvant to Chemotherapy in Reducing Adverse Effects in a 56 Year Old Female Patient Reported with Stage 4 Advanced Ovarian Cancer

Favorite
T1530-13-86 - Establishment of a Hollow Fiber Infection Model for Preclinical PK/PD Evaluation of Novel Spectinamide Antituberculosis Agents

Favorite
M0930-13-88 - Estimation of Brain Entry Rate of Oxycodegol, a Selective, Long-Acting Full µ-opioid Receptor Agonist, in Humans Using PBPK-PD Modeling

Favorite
M1230-13-86 - Evaluating Food Effects on Oral Drug Absorption in Infants: An Exploratory Study in Healthy Adults

Favorite
T0930-13-85 - Evaluation of Different Inhibitory Effect of Itraconazole and Clarithromycin on Hepatic CYP3A Activity Using Oral Sildenafil and Endogenous Metabolic Markers for Hepatic CYP3A Activity

Favorite
T1430-13-85 - Evaluation of Dried Blood Spot Sampling Method toward Therapeutic Monitoring of Radotinib in the Treatment of Chronic Myeloid Leukemia

Favorite
M1430-13-88 - Evaluation of Methamphetamine and Amphetamine Disposition Discrepancy upon Selegiline Transdermal Patch Administration in Healthy Volunteers Versus Special Populations Using PBPK Modelling

Favorite
T1030-13-85 - Evaluation of U.S. FDA Approved Generic Oral Solution Products

Favorite
W0930-13-89 - Exploring Clinical Relevance of Dissolution Testing by Physiologically Based Biopharmaceutics Modeling (PBBM)

Favorite
M1130-13-85 - Exposure Predictions of Prodrug CZ48 and Active Campothecin, CPT, in Humans: Population PK Modeling and Simulation of CZ48 and CPT

Favorite
T1030-13-89 - FDA Perspective on Current Challenges in Bioequivalence Evaluation for Topical Dermatologic Corticosteroid Abbreviated New Drug Applications (ANDAs)

Favorite
T1030-13-88 - FDALabel: Database on the Amazon Cloud for Drug Labeling Information

Favorite
M1030-13-87 - Gender Differences in Pharmacokinetics, Excretion Pattern, and Tissue Distribution Following Administration of 4-n-nonylphenol in Rats

Favorite
T0930-13-84 - Impact of Operator Variability on the Reproducibility of Tape Stripping Results

Favorite
T1230-13-85 - In Vitro and In Vivo Interpretations of Effect of Isoflurane Anesthesia on Membrane Lipids of Blood-Brain Barrier: Potential Clinical Implications

Favorite
M0930-13-86 - In Vitro Study of Novel Bone-Targeting Angiotensin 1-7 Conjugate Effects on Cell Survival and mRNA Expression of Different Components of Renin-Angiotensin System in Various Cancer Cell Lines

Favorite
W1030-13-87 - Inflammation Responsive Drug Delivery for Localized Opioid Release to Combat Chronic Pain in Osteoarthritis

Favorite
T1230-13-83 - Influence of Rifampin-Mediated OATP1B1/1B3 Inhibition on the Pharmacokinetics of Clazosentan

Favorite
T1330-13-86 - Investigating the Impact of Crohn's Disease on Oral Budesonide Pharmacokinetics Using In Vitro Dissolution Testing and PBPK Modeling

Favorite
T1430-13-84 - Investigations of Catheter Obstructions from Materials Collected in Patients with Type 1 Diabetes Treated by Intraperitoneal Insulin Infusion

Favorite
T1430-13-87 - IPE between PharmD and Exercise Science Students

Favorite
M0930-13-85 - Lipidomic Alterations in Docetaxel-Resistant Prostate Cancer

Favorite
T1530-13-84 - Longitudinal Impacts of Roux-en-Y Gastric Bypass Surgery on the Atorvastatin and Simvastatin Metabolisms and 3D PK/PD Correlations

Favorite
T1530-13-83 - Mass Balance, Metabolic Disposition, and Pharmacokinetics of [¹⁴C]Etrasimod Following Oral Administration to Healthy Male Volunteers

Favorite
M1330-13-86 - Mean Residence Time Values for Monoclonal Antibody Drugs

Favorite
T1530-13-85 - Mechanism-Based Population Pharmacokinetic/Pharmacodynamic (PKPD) Modeling of ISIS 702843, a TMPRSS6 Targeting Antisense Oligonucleotide (ASO) to Guide Early Clinical Development

Favorite
T1130-13-84 - MEK1/2-Mediated Chemosensitization in Glioblastoma Cells

Favorite
M1430-13-85 - Microdosing Strategy for Absolute Bioavailability Studies: A Case Study on ¹³C-Venetoclax, from Development to the Clinic

Favorite
W0930-13-83 - Multi-scale PK Modeling of Biotherapeutic Formulations Injected in Human Subcutaneous (SC) Tissue

Favorite
W1030-13-86 - Nasal Immunization Induces Nicotine-Neutralizing Antibodies in Blood and Lung Mucosal Secretions

Favorite
T1230-13-84 - New Oral Diabetic Macular Edema/Diabetic Retinopathy Treatment Using First-in-Class Mode of Action

Favorite
T1330-13-83 - Nonlinear Mixed Effect Modeling of Donepezil After Oral Administration

Favorite
M1230-13-89 - PBPK and Its Virtual Populations: Simulation of Pharmacokinetic Parameters in Pediatric Population Using Developed Furosemide Simcyp Model

Favorite
T0930-13-87 - Pharmacokinetic Drug-Drug Interaction between Teneligliptin and Atorvastatin in Healthy Male Adults

Favorite
M1330-13-85 - Pharmacokinetic Interaction between Fixed-Dose Combination of Ezetimibe/Rosuvastatin and Fixed-Dose Combination of Telmisartan/Amlodipine in Healthy Male Subjects

Favorite
M1030-13-83 - Pharmacokinetic Similarity of Test and Reference Anti-epileptic Drugs in Generic Brittle Patients with Epilepsy

Favorite
W1130-13-83 - Pharmacokinetic Study of Physically Manipulated Oxycodone Hydrochloride Products Following Nasal Insufflation in Recreational Opioid Users

Favorite
T1030-13-84 - Pharmacokinetics of Diroximel Fumarate in Healthy Volunteers, Adults with Renal Impairment and Patients with MS

Favorite
W0930-13-85 - Physiologically Based Pharmacokinetic Model for Voriconazole and Prediction of Its Interactions with Midazolam and Alfentanil

Favorite
M1430-13-83 - Population Modeling for the Investigation of Factors Affecting the Clinical Outcome in Epileptic Patients Under Levetiracetam Therapy

Favorite
M1130-13-86 - Population Pharmacokinetics of Cefazolin Before, During, and After Cardiopulmonary Bypass in Japanese Patients Undergoing Cardiothoracic Surgery

Favorite
W1230-13-86 - Potent Inhibitory Effect of Vandetanib on Methotrexate-Induced Epithelial-Mesenchymal Transition in Alveolar Epithelial A549 Cells

Favorite
M1230-13-88 - Predicting Shrinkage of Individual Parameters in More Complex NLME Models Using Bayesian Fisher Information Matrix

Favorite
W0930-13-86 - Prediction of Pulmonary Pharmacokinetics of Spectinamide 1599 in Humans Based on Rodent Pharmacokinetic Data Using a Permeability-Limited Lung Physiologically Based Pharmacokinetic Model

Favorite
W1130-13-86 - Randomized, Open-Label, Single-Dose, Crossover Pharmacokinetic Study of Multiple-Dose and Single-Dose Vial Epoetin Alfa-Epbx, an Epoetin Alfa Biosimilar, by Subcutaneous Dosing in Healthy Subjects

Favorite
W1230-13-85 - Relationship Between TGF-β1-Induced EMT and Monocarboxylate Transporter 1 (MCT1) in Alveolar Epithelial A549 Cells

Favorite
M1230-13-83 - Relationship of AEDs to Generic Brittleness and to Switch Problems in Patients with Epilepsy

Favorite
M1130-13-88 - Role of IL-23 suppression in psoriasis – insights from meta-analysis of clinical data

Favorite
T1030-13-83 - Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACT017, an Anti-platelet GPVI (Glycoprotein VI) Fab in Healthy Volunteers

Favorite
M0930-13-87 - Steady-State Trough Concentrations and Their Relationship to Selected Demographic and Clinical Response Measures in Etrasimod-Treated Patients with Moderately-to-Severely Active Ulcerative Colitis

Favorite
M1030-13-86 - The Effect of the Local Tissue Response on the Pharmacokinetics of Long-Acting Injectable Formulations

Favorite
T1430-13-86 - The Expression of SLC7A11 Transporter in Ovarian and Colon Cancer Tissues at Different Stages of Development

Favorite
M1130-13-83 - The Impact of Dose and Time Delay Between Administration and Absorption on Irbesartan Pharmacokinetics and Pharmacodynamics

Favorite
T1530-13-88 - The Impact of Glycosylation Composition on Pharmacokinetics (PK) of Monoclonal Antibodies

Favorite
W1130-13-85 - The Pharmacokinetic Differences between Humans and Animals of KZR-616, a First-in-Class, Selective Immunoproteasome Inhibitor, in Two Clinical Formulations

Favorite
W1230-13-87 - The Use of Concatemer Subunit Constructs to Study the Pharmacology of α4- and α6-Containing Neuronal Nicotinic Acetylcholine Receptor

Favorite
M1230-13-85 - The Viscosity of Contents in the Upper Gastrointestinal Lumen of Adults in the Fed State

Favorite
M1130-13-84 - Translating Progressive Disease Pharmacokinetic Model to Clinical Application: An Interactive Dosing Guidance Support Tool for Riluzole Therapy in Spinal Cord Injury Patients

Favorite
T1030-13-86 - Trends in the Design and Conduct of Pharmacokinetic Studies in Patients with Impaired Hepatic Function

Favorite
M1430-13-84 - Using a Physiologically-Based Pharmacokinetic Absorption Model to Establish Clinically Relevant Dissolution Safe Space for Oseltamivir in Adult and Pediatrics

Favorite
M1230-13-87 - Using Resampling to Improve Model Selection in Pharmacometrics

Favorite
M1530-13-84 - Visualizing and Evaluating the Impact of Immunogenicity on Pharmacokinetics

Favorite
W1030-13-85 - Zt/g4-MMAE, a RON Receptor-Targeted Antibody-Drug Conjugate with Potent Anti-tumor Activity Against RON-Overexpressing Solid Tumor Models

Favorite
Formulation and Quality
M1030-02-08 - A Cancer-Targeting Liposomal Delivery System for Photodynamic Diagnosis and Therapy of Cancers in Peritoneal Cavity

Favorite
M1430-06-41 - A Clinically Relevant Non-sink Dissolution Method for ASD-Based Formulations

Favorite
M1430-01-04 - A Comparative Study of Lipid-Based Nano Drug Delivery System Using MSP1D1 Protein and Poloxamer 407

Favorite
T1330-04-27 - A Comparative Study of Various Approaches to Generate Soluble Dosage Forms

Favorite
W0930-07-45 - A Comparison Among the In Vitro Release Profiles and the In Vitro Absorption Profiles of Caffeine from Three Lipophilic Topical Formulations

Favorite
T1230-04-24 - A Comparison of KinetiSol®-Processed and Spray Dried Amorphous Solid Dispersion Release Kinetics via pH-Dilution Dissolution

Favorite
T1230-05-32 - A Comparison of the Economical and Experimental Outcomes of Different Ratios and Types of Fillers in Direct compression Process of Solid-Dosage Form in order to Evaluate the CQA of Glucosamine Tablets

Favorite
W1030-02-09 - A Comparison of the Permeability of Lidocaine Formulations Through a Shed Snake Skin Model of Stratum Corneum Using Franz Diffusion Chambers and an Air Interface Chamber

Favorite
M0930-01-01 - A Comparison of the Spray Characteristics of Aqueous and Non-aqueous Multi-dose Nasal Spray Formulations

Favorite
M1330-01-05 - A Corneal-Penetrating Eye Drop Formulation for Enhanced Therapeutic Efficacy of Soft Corticosteroids against Anterior Uveitis

Favorite
T0930-02-08 - A Fast HPLC Method for Drug Dimerization Rate and Drug Release Tests

Favorite
M1530-05-34 - A Film Coating Formulation That Has a Better Performance for Tablet Printing

Favorite
W1230-03-15 - A Functional Wound Dressing Intended for Cutaneous Leishmaniasis

Favorite
M1330-04-23 - A Fundamental Study on Strain Rate Sensitivity of Spray Dried Solid Dispersions

Favorite
T1330-01-07 - A Long-Acting Thermo-Responsive Injectable Formulation of Tin Protoporphyrin IX Dichloride: Development and In Vitro In Vivo Evaluation for Tuberculosis Treatment

Favorite
T1330-06-37 - A Modified Langmuir-Like Equation to Account for Solvent Displacement in Drug Adsorption from Aqueous Solutions

Favorite
T1530-02-14 - A New Injectable Liquid Crystal System for One Month Delivery of Leuprolide

Favorite
M1030-05-32 - A New Kollicoat^® Polymer Coating as a Moisture Barrier for Soft Gelatin Capsules

Favorite
T1430-04-27 - A Novel Amorphous Solid Dispersion Based on Drug-Polymer Complexation

Favorite
T1430-03-21 - A Novel Approach to Improve Bioavailability of Poorly Water-Soluble Drugs

Favorite
M1230-03-17 - A Novel Laser Diffraction Methodology for the Characterization of ASD Speciation Events - An Itraconazole: HPMC AS Case Study

Favorite
T1430-06-38 - A Novel Patient-Specific In Vitro Drug Release Model That Allows Assessing the Variability of In Vivo Drug Release in Patients Suffering from Parkinson´s Disease

Favorite
M1130-07-47 - A Novel Stereolithographic Platform for 3D-Printing a Six-Layered Printlet Containing Different Drugs

Favorite
M1130-02-08 - A Novel Sunflower Oil-Based Polyol Urethane for Olanzapine Delivery

Favorite
T1230-03-18 - A Novel Ufosomal Formulation for Topical Delivery of Clotrimazole

Favorite
W0930-05-33 - A One-Step Continuous Twin Screw Process Using Neusilin® S2 to Improve Solubility of Poorly Soluble Drug Indomethacin

Favorite
W1030-04-23 - A Phase I Study to Screen Multiple Solubility-Enhancement Formulation Technologies and an Assessment of Food, PPI and Dose Linearity with the Selected Formulation of BOS172767 in Healthy Volunteers

Favorite
T1330-07-43 - A Polymeric Bio-adhesive Film Forming Topical Spray Formulation Providing a Bi-phasic Release Profile for the Treatment of Neuropathic Pain

Favorite
M1130-06-40 - A Selective and Sensitive Method Development and Validation of 1,1-Dimethyl-3-Hydroxy-Pyrrolidinium Bromide Impurity in Glycopyrrolate Bromide by Liquid Chromatography – Tandem Mass Spectoscopy

Favorite
M1030-07-47 - A Straightforward Compounding Method for Reproducible Homogenous Carbomer 940 Based Lidocaine Gel

Favorite
T1030-04-26 - A Strategy to Use Raman Spectroscopy to Enable High-Throughput Screening of Oral Lipid Drug Formulations

Favorite
M1130-01-07 - A Study on the Effect of Drug-Polymer Ratio on the Characteristics of Levonorgestrel Microparticles Prepared Using Poly-L-lactic Acid

Favorite
T1530-07-49 - A Supersaturatable Self-emulsifying Drug Delivery System for the Weakly Basic Drug Carvedilol to Improve Its Bioavailability

Favorite
M1430-04-25 - A Surfactant-Based Binary and Triple Solid Dispersion Technique for the Dissolution Enhancement of Mosapride

Favorite
T1130-06-39 - Abbreviated Dynamic Vapor Sorption (DVS) Analysis Method for the Determination of Amorphous Content in Micronized Drug Substance

Favorite
M1030-06-39 - Absorptive Dissolution Testing: An Improved Approach to Study the Impact of Residual Crystallinity on the Performance of Amorphous Formulations

Favorite
T1430-05-29 - Abuse Deterrent Compositions of Poly(ethylene Oxide) and Crosslinked Carboxymethylcellulose

Favorite
M1330-07-47 - Abuse-Deterrent Therapeutic Complexes of Dextromethorphan and Crosslinked Starch and Cellulose Derivatives

Favorite
W1030-01-07 - Accelerate Development of Topical Cream Drug Product Using a Common Platform Base Formulation

Favorite
M1230-06-36 - Accelerated siRNA Analytical Denatured IP-RP UPLC Method Development Using Fusion Software

Favorite
T1530-06-40 - Accelerated Stability Modeling of Drug Products using ASAPprime®

Favorite
M0930-04-23 - Acoustic Fusion as a New Method for Generating Small Scale Amorphous Dispersion Formulations

Favorite
M1030-03-17 - Active Natural Oil-Based Nanoemulsion Containing Tacrolimus Loaded Gel for Synergistic Anti-psoriatic Efficacy

Favorite
T1530-07-43 - Additive Manufacturing of Pharmaceutical Tablets with Wider Range of Drug Loadings via FDM 3D Printing

Favorite
M1230-05-33 - Agonist and Antagonist Release Modulated Microenvironment Sensitive Pills for the Prevention of Accidental or Abuse Related Use of Sleeping Pills

Favorite
T1330-02-13 - Albumin Drug Conjugate Delivering Highly Potent Drug with Improved Tumor Accumulation and Anti-tumor Efficacy

Favorite
T1530-05-35 - Alterations in Tablet Properties and Formation of Internal Cavities Account for the Humidity-Induced Deterioration of Orally-Disintegrating Tablet Hardness

Favorite
T1330-04-26 - Ameliorating Brain Delivery of Paliperidone via Lipid Nanoconstructs: Formulation and In Vitro Evaluation

Favorite
W0930-05-35 - Ammonio Methacrylate Co-polymer Nanoparticles Serve as Effective Anticancer Immunotherapeutics

Favorite
M1330-03-18 - Amorphous Nanocomplex of Efavirenz Loaded Vaginal Film (EZfilm) for Preexposure Prophylaxis (PrEP) of HIV

Favorite
T1430-04-24 - Amorphous Solid Dispersion and Self-Microemulsifying Drug Delivery System Comparison of a Novel Compound In Vitro and Bioavailability In Vivo

Favorite
T1430-03-18 - Amphotericin B Loaded Nanostructured Lipid Carriers for Ocular Drug Delivery in Cases of Ocular Fungal Infections: In Vitro and In Vivo Evaluations

Favorite
M1330-05-29 - An Easy-to-Swallow Immediate Release Coating Formulation with Instacoat Aqua Lustre

Favorite
T1030-02-14 - An Innovative Calculation-Based Approach for Biologics Ruggedness Study Sample Preparation

Favorite
T0930-01-03 - Analysis of HPMC and Gelatin Capsules for Optimal Aerodynamic Performance of Salmeterol-Fluticasone Inhalation Formulation

Favorite
W1030-03-16 - Analysis of Tamoxifen Localization in The Polyethyleneglycol-Polylactide Block Copolymer Micelles with Different Physicochemical Properties by Solid Phase Extraction

Favorite
W1230-01-03 - Analytical and Biophysical Characterization of lyophilized Immunoglobulin G Tablet Stability during the Compaction and Storage

Favorite
W1030-06-39 - Analytical Method Development, Validation and Stability Studies of a Novel Anti-cancer Drug IND 2

Favorite
T1330-05-31 - Apigenin Self-Nanoemulsifying Drug Delivery System for Enhancing Oral Bioavailability: In Vitro, In Vivo, and Stability Evaluations

Favorite
M0930-07-44 - ApolipoproteinE2 Gene Delivery Using Functionalized Liposomes Across Blood Brain Barrier for Treatment of Alzheimer’s Disease

Favorite
M1030-03-16 - Application and Evaluation of Strat-M™ Artificial Membrane for Predicting Diffusion in Skin Permeation Experiments

Favorite
T1230-06-40 - Application of Freethink's ASAPprime Software to Analyze and Predict the Impact of Storage and Handling Temperature Excursions for Cold-Chain Handling of Netarsudil Ophthalmic Solution

Favorite
M1330-05-33 - Application of Hypromellose Phthalate (HPMCP) and Smart-Ex in the Development of Multiple Unit Pellet System (MUPS) Orally Disintegrating Tablet (ODT) for Lansoprazole 15mg

Favorite
T0930-06-40 - Application of Near Infrared Spectroscopy and Chemometrics for the Quantification of Acetaminophen in Bulk and in Soft Gelatin Capsules

Favorite
T1430-06-41 - Application of NIR for Improvement in Blending Process

Favorite
T1030-03-19 - Application of Plackett-Burman Design to Study the Effect of In Vitro Test Conditions on the Permeation Rate of Etofenamate and Diclofenac from Selected Topical Products through Strat-M^TM Membrane

Favorite
M1530-05-35 - Applications for the ProCepT Tri-fluid Nozzle in Spray Drying

Favorite
T1230-07-47 - Applying Physiologically Based Pharmacokinetic Modeling and Simulation for Quality Risk Assessment: Setting Clinically Relevant In Vitro Dissolution “Safe Space” Specifications for a BCS Class II Drug

Favorite
W1130-03-19 - Approaches to Develop Acyclovir Gastro-Retentive Formulations Using Hot Melt Extrusion Technology

Favorite
M1330-06-36 - AS04 Enhances Mucosal AndSystemic Immunity To Antigens Following Intranasal Administration

Favorite
M1530-01-01 - Assay of Potassium Bitartrate Using Ion Chromatography

Favorite
T1030-07-45 - Assessing the Effects of Different Lipids on Bioavailability of Cannabidiol following Oral Administration

Favorite
W1130-03-21 - Assessment of Biosimilarity Using Forced Degradation: Rituximab, Bevacizumab, and Trastuzumab Originators and Biosimilars

Favorite
M1530-07-46 - Assessment of Patient Exposure to Leachables from Lyophilized Drug Formulations Following Reconstitution, Storage, and Administration via Polymeric Packaging/Delivery Systems

Favorite
W1030-02-10 - Assessment of Quality Control Parameters and In Vitro Bioequivalence/Interchangeability of Multi-source Marketed Atorvastatin Calcium Tablets in the State of Qatar

Favorite
T0930-04-22 - Assessment of the Impact of an Unusual Reaction between API and HPMCAS Polymer on Long Term SDD Storage

Favorite
T1130-06-38 - BCA Protein Content Determination on Microplate Support: Suitability Study for Alzheimer Vaccine Treatment

Favorite
T0930-02-14 - BE Discriminant In Vitro Dissolution Test for Two Ibuprofen Formulations: Relevance of Buffer Strength and Fluid Volume

Favorite
W1130-04-28 - Bedaquiline-Cyclodextrin Molecular Inclusion Complex for Effective Treatment of Multidrug Resistant Tuberculosis

Favorite
T1030-05-35 - Beta-cyclodextrin Derivatives as a Viable Tool for a BCS Class II Drug (Griseofulvin) Solubilizations

Favorite
M1430-02-12 - Binary Liposomal Platform for the Low-Intensity Light-Induced Release of Doxorubicin

Favorite
M1430-01-02 - Bioadhesive Nanoemulsions Improve Cellular Uptake and Cytotoxicity of Piplartine In Mammary 3d Tumor (Spheroids)

Favorite
M1230-03-16 - Biocompatible Tadalafil Nanoemulsion for Management of Pediatric Pulmonary Hypertension

Favorite
W1030-04-27 - BioDuro Solution Engine: Rapid Development of Regorafenib Spray Dry Dispersions with Minimal Material Use

Favorite
T1330-05-35 - Biorelevant In Vitro Testing of Electrospun Polymeric Nanofibers of Weak Bases with Solubility Limited Oral Absorption: Albendazole as a Case Example

Favorite
M1330-02-09 - Brain Targeting Nanoparticles of Neuropeptide Y: Fabrication and Characterization

Favorite
T1430-06-36 - Captisol^® improves the Aqueous Solubility of a Poorly Water Soluble Drug Elvitegravir

Favorite
W0930-05-30 - Carbopol^® Polymers and Noveon^® Polycarbophil Mucoadhesive Properties in Liquid and Semisolid Formulations

Favorite
M1030-05-31 - Case Study: Formation and Elimination of Stringers on Eudragit Tablet Coatings

Favorite
M0930-07-43 - Cell Assembly-Mediated Delivery of Checkpoint Inhibitors for Leukemia Immunotherapy

Favorite
M1230-06-39 - Challenging Assay Development for Two Different Lidocaine Topical Systems by Using UPLC-PDA in Support of Clinical Studies 2 - Clinical Results and Application

Favorite
M1330-02-13 - Characterization and Pharmacokinetics of a Novel Nano-Lipid Delivery System of Cannabidiol

Favorite
T1130-06-37 - Characterization and Quality Comparison of AmBisome® and Several Generic Products

Favorite
M1230-06-38 - Characterization and Validation of an In Vitro Microglia Cell Line Model to Screen Potential Therapeutics for Neuropathic Pain

Favorite
T1230-05-33 - Characterization of Directly Compressible Starch for Use in a Continuous Manufacturing Line

Favorite
M1530-05-31 - Characterization of Physical Properties of Novel Calcium-Phosphate-Based Starter Pellets (PharSQ^® Spheres CM)

Favorite
T1130-06-36 - Characterization of Protein Therapeutics: Detection of Small Peptide Aggregates with FFF/MALS Technology

Favorite
M1030-05-35 - Characterization of Spray-Dried Aggregates for Tablet Formulation with Microstructure 3D Imaging Analytics

Favorite
W1130-02-13 - Characterization of the Partition Rate of 2-Naphthol and Ritonavir across the Water - Octanol Interface and the Influence of Common Pharmaceutical Excipients

Favorite
W0930-07-49 - Characterization of the Performance of a Novel Esophageal Drug Delivery System in Humans

Favorite
M1030-02-12 - Characterization Optimization Temozolomide Loaded Magnetic Nanoparticles–In Vitro Evaluation to Study P-gp/EGFR Inhibition Mediated Therapy for Glioblastoma Multiforme

Favorite
W1130-05-35 - Characterizing Deformation Properties of Directly Compressible Excipients Using a Compaction Emulator

Favorite
W1030-06-42 - Characterizing the Effect of Flow Aid Additives on Pharmaceutical Powders

Favorite
M1030-02-14 - Chelerythrine Chloride Nanoparticles in Triple Negative Breast Cancer Chemotherapy

Favorite
T1330-01-05 - Cholecalciferol Solubilization by Hydroxypropyl-β-Cyclodextrin (HPBCD)

Favorite
W1030-05-31 - Chrono Modulated Multiple Unit Particle Systems (MUPS) for Treatment of Angina via Hot Melt Extrusion Technology

Favorite
W0930-04-25 - Co-amorphous Spray Dried Dispersion vs. Physical Mixture of Resveratrol and
Favorite
M0930-04-22 - Cocrystal Solubility Advantage Diagrams, Additive Selection, and Drug Supersaturation-Precipitation Behavior

Favorite
M1130-06-38 - Cocrystallization from Stable Hydrate by Heating Method Using Hot-Stage Low-Frequency Raman Spectroscopy

Favorite
T1030-03-21 - Co-delivery of Adenosine and Niacinamide Utilizing Solid Lipid Nanoparticles for Anti-Wrinkle and Whitening of Skin

Favorite
T0930-02-10 - Co-delivery of MicroRNA 708 and Paclitaxel in Layer-by-Layer Assembled Mesoporous Titania Nanoparticle for Combined Chemotherapy

Favorite
M1230-05-31 - Coenzyme Q10 Orally Disintegrating Tablets

Favorite
M1530-01-03 - Co-formulating a Novel Combination Therapy of Paclitaxel and Calcipotriol for the Treatment of Pancreatic Ductal Adenocarcinoma Using Response Surface Methodology

Favorite
T1030-02-10 - Combination Drug Delivery from an Antibiotic-Releasing Bone Void Filling (ABVF) Putty for Biofilm Related Orthopedic Infection Treatment

Favorite
T1230-02-09 - Combination NIR Therapy and Regulatory T Cell Modulation Using Layer-by-Layer Hybrid Nanoparticles for Effective Cancer Photoimmunotherapy

Favorite
T1530-02-10 - Combination of Personalized Nanovaccines and a Customized In Situ Anti-PD-L1 Depot for Precise Cancer Therapy via a Sequential Immune Enhancement and Immune Normalization Strategy

Favorite
T1430-01-01 - Combinatorial Approach for the Treatment of Neovascular Age-Related Macular Degeneration Using Anti-HIF and Anti-VEGF Agents

Favorite
W1130-02-09 - Combined Chemophototherapy by Lanreotide-Conjugated Hybrid Nanoparticles Wrapped Polyaniline and Methotrexate in Treatment of SSTR-Expressing Cancer

Favorite
M1230-02-12 - Combined Effects of the Supersaturation Rates and Doses on the Kinetic-Solubility Profiles of Amorphous Solid Dispersions Based on Water-Insoluble PHEMA Hydrogels: Proof of Concept in Rats

Favorite
W1030-06-41 - Combining ssHDX and MALDI-HDX as a Novel Semi-automated HTA Workflow to Assess and Predict the Stability of Solid-Dose Peptides Following Mixing and Lyophilization with Various Excipient Formulations

Favorite
T1030-07-43 - Comparative Dissolution and pH Solubility Studies of Indomethacin Solid Dispersions to Explain the Effect of Polymers’ Order of Addition

Favorite
T1130-05-30 - Comparative Dissolution of Different Over-the-Counter (OTC) Acetaminophen Extended-Release Tablets

Favorite
M1330-05-30 - Comparative Evaluation of Commonly Employed Plasticizers in Soft Gelatin Capsules

Favorite
W0930-06-42 - Comparative Evaluation of Pharmaceutical Powders Flow Using Different Analytical Methodologies

Favorite
M1030-01-07 - Comparison of Calcium Glycerol Phosphate Versus Calcium Gluconate Mediated In Situ Gelling of Alginates for Ocular Drug Delivery.

Favorite
T1330-03-21 - Comparison of Human Cadaver Skin with Freshly Frozen Human Surgical Skin for Bioavailability and Bioequivalence Studies

Favorite
M1030-06-41 - Comparison of Solubility and Dissolution Behavior of Ibuprofen and Ketoconazole Immediate Release (IR) Tablets in Biorelevant Medium Made from Commercial Powder or from Scratch

Favorite
T1230-01-07 - Comparison of the Effectiveness of Sildenafil Citrate Air-Jet Nebulizer and Dry Powder Inhaler

Favorite
T1430-04-25 - Comparison of Two In Silico Modeling Programs, ADMET Predictor Ò and Percepta Ò to Predict Intrinsic Solubility and pK_a of Poorly Soluble Drugs

Favorite
M1330-02-10 - Comparison Study Between SLN and NLC: Release of Rhodamine 123

Favorite
M1330-06-37 - Compatability of Flavoring Agents in Compounding Extemporaneous Omeprazole Oral Liquid

Favorite
T0930-03-15 - Composite Collagen, Alginate and Hyaluronate Based Wound Dressings Loaded with Protein for the Treatment of Chronic Wounds

Favorite
M0930-05-32 - Comprehensive Binder Comparison in Metformin Extrusion Granulation

Favorite
T1430-05-33 - Compression Profiles of a Directly Compressible Starch using Compaction Simulation and High-Speed Tablet Press

Favorite
T1130-03-21 - Conformational Switch-Based pH-Sensitive Liposomes Enhance the Anticancer Activity of Doxorubicin in an Orthotopic Murine Model of Breast Cancer

Favorite
M1530-06-36 - Considerations in the Development and Implementation of Analytical Methods for Understanding and Controlling the Chemical Stability of Formulated Synthetic Peptides

Favorite
M1030-04-24 - Construction of Thermodynamic Phase Diagrams to Predict Drug-Polymer Miscibility in Hot-Melt Extrusion

Favorite
W0930-03-17 - Continuous Production of Raloxifene Hydrochloride Loaded Nanostructured Lipid Carriers Using Hot-Melt Extrusion Technology

Favorite
M0930-06-42 - Contributions to Dissolution Enhancement in Fed-State Biorelevant Media

Favorite
M1430-05-33 - Controlled Release to the Lower Gastrointestinal Tract Using Liquid Filled Hard Capsules

Favorite
M0930-05-35 - Correlation of In Vitro Mucoadhesion and Contact Angles of Hypromellose

Favorite
W1130-01-07 - Correlations between BSA Intrinsic Fluorescence and Aggregation using Multivariate Experimentation

Favorite
T1430-07-43 - C-peptide Determination in Diabetic Rats Treated with Capsules Containing Purified Leaf Extract of Mangifera indica and Glibenclamide or Metformin

Favorite
W1030-02-12 - Critical Considerations When Using PAMPA for the Assessment of Membrane Mass Transfer from Supersaturated Solutions of Lipophilic Drug Dompound

Favorite
W1030-07-44 - Critical Quality Attributes of Topical Pharmaceutical Foams

Favorite
M1330-03-20 - Critical Risk Assessment and Prioritizing: A New Tool to Prioritize and Simplify the Toxicological Risk Assessment in the Manufacture of Pharmaceutical Products in Shared Facilities

Favorite
M0930-07-47 - Crosslinked Carboxymethyl Starch and Carboxymethyl Cellulose-Based Formulations: An Innovative Approach to Deter Opioid Drug Abuse

Favorite
T0930-04-24 - Crystal Seed Growth Poisoning by Polymeric Additives in Non-Sink Dissolution of Amorphous Solid Dispersions Containing Residual Crystallinity

Favorite
M1330-05-31 - Crystallographic Evidence of Reduced Dissolution by Surfactant: Salt Formation Between Norfloxacin and Sodium Lauryl Sulfate

Favorite
M1430-03-21 - Curcumin and Cyclosporine Loaded Bioadhesive Pellets for Colon Targeting in the Management of Inflammatory Bowel Disorder: Development, Optimization, In Vitro and Pharmacodynamic Evaluation

Favorite
M1330-07-43 - Cytotherapy for Parkinson's Disease - Smart Microcapsules for Long Term Treatment

Favorite
W1130-03-17 - Dabigatran Etexilate Loaded Nanoemulsion Demonstrating Enhanced Oral Bioavailability and Anticoagulant Activity

Favorite
M0930-06-39 - Dapoxetine Hydrochloride and L-arginine Solid Dispersion Film Formulation for Premature Ejaculation Treatment

Favorite
T1430-03-15 - Decorated HDL Nano-particulates Inspired Tumor Extracellular Dissociation for Site-Specific Chemo-immunotherapy

Favorite
M1230-02-10 - Degradable Hollow Mesoporous Organosilica Nanoparticles for Drug Delivery

Favorite
T1130-06-40 - Degradation Products Profiling of Imatinib Using UHPLC and High Resolution Mass Spectrometer with Muitple Dissociation Techniques

Favorite
W0930-06-40 - Delayed Release Drug Products Behave Differently in Physiological Bicarbonate Buffer

Favorite
M1430-03-17 - Delivery of Heparin via Laser-Generated Micropores

Favorite
M0930-03-15 - Dendrimer-Based Antibiotics for the Treatment of Bacterial Biofilms

Favorite
M1030-03-20 - Dermal and Transdermal Delivery of Oxicams Using Deformable Liposomes

Favorite
T0930-03-17 - Dermal Rutin smartCrystals – Skin Friendly Commercial Concentrates for Anti-pollution Products

Favorite
M1430-07-48 - Dermal Wound Bandages Made from 3D Printed Poly-l-lactic Acid Mats Coated with Polyethylene Glycol and Loaded with Neomycin

Favorite
M0930-04-26 - Design and Characterization of a New Drug-Herb Isoniazid-Curcumin Cocrystal for Potentially Improving Tuberculosis Treatment

Favorite
T1030-04-27 - Design and Evaluation of Olaparib Nanostructured Lipid Carriers for Bioavailability Enhancement Toward Breast Cancer Treatment

Favorite
W1030-04-24 - Design and In Vitro Characterization of Lipid Carriers Loaded with Antiretroviral for Oral Drug Delivery

Favorite
M1530-02-09 - Design of a Two-Phase System for the Sustained Delivery of Growth Factors for Bone Tissue Engineering Applications

Favorite
M1330-05-35 - Design of Chewable Tablet Dosage Forms in Light of the New FDA Guidance

Favorite
T1130-04-27 - Design of Lipid-based Solid Dispersion Systems for Increasing Dissolution Rates of Celecoxib

Favorite
T1030-07-44 - Design of Surface Modified Liposomal Nanoparticles for Targeted Delivery of Gene to the Brain

Favorite
W1230-05-30 - Design of Ternary Amorphous Solid Dispersions Containing a High Viscosity Polymer and Mesoporous Silica by Hot Melt Extrusion to Produce a Heightened Parachute Effect During Dissolution

Favorite
W1130-07-44 - Design of Tubular Electrospun Grafts Containing Vancomycin for Vascular Tissue Regeneration

Favorite
M1230-01-07 - Design, Development, and In Vitro Characterization of a New 8-aminoquinoline Derivative Loaded Solid Lipid Nanoparticles for Relapsing Malaria

Favorite
M1030-07-46 - Design, Formulation, and In Vivo Evaluation of 3D Printed Dexamethasone Polypropeylene Fumarate (PPF) Biodegradable Stents for Vascular Applications

Favorite
M1030-02-11 - Design, Synthesis and Characterization of Biotinylated Polymeric Micelles to Combat Breast Cancer

Favorite
M1330-02-08 - Designing a Novel High Hydroxyl Oil-Based Polyol as a Drug Delivery Carrier

Favorite
T1230-06-41 - Detection of Host Cell Proteins (HCPs) in Biotherapeutics with Reproducible UHPLC and HRAM Orbitrap-Based MS

Favorite
M1130-06-41 - Detection of Silicon as a Process Impurity in Captisol® (Betadex Sulfobutyl Ether Sodium) by ICP-MS

Favorite
W0930-02-08 - Determination and Identification of Biomarkers for Normal and Diabetic Rats under Aerobic and Anaerobic Exercise

Favorite
M1230-07-46 - Determination of Betadex (β-Cyclodextrin) According to the USP Betadex Sulfobutyl Ether Sodium Monograph and Possible Improvements

Favorite
T1230-06-37 - Determination of Residual Hydroxylamine in Complex Formulations

Favorite
M1330-06-40 - Developing a Fast, Non-Destructive Terahertz Dissolution Assay of Tablets During Manufacture

Favorite
W1230-02-14 - Developing an Affinity-Based Subcutaneous Formulation for a GLP-1-Like Agonist

Favorite
T0930-07-44 - Developing an Oral Dissolving Film (ODF) Formulation of Microparticulate Gonorrhea Vaccine

Favorite
T1230-06-38 - Development and Application of Riboflavin and Diphenhydramine Impurity Solutions for Pharmacopeial Testing

Favorite
T1030-06-40 - Development and Application of USP Apparatus 4 for In Vitro Drug Release from Omega-3-Acid Ethyl Esters Capsules

Favorite
T1530-04-26 - Development and Characterisation of Ketoprofen-Benzocaine Deep Eutectic Mixtures

Favorite
M1530-04-26 - Development and Characterisation of Procaine-Ketoprofen Deep Eutectic Mixtures

Favorite
T1230-07-44 - Development and Characterization of 3D Printed Delayed-Release Orodispersible Film Loaded with Lansoprazole Drug

Favorite
M1230-01-05 - Development and Characterization of an In Situ Thermosensitive Electro-Responsive Nanogel-Composite for Controlled Release of a Bioactive Agent for Nose-to-Brain Delivery

Favorite
M1430-03-18 - Development and Characterization of Nanoparticulate Delivery System for the Treatment of Cutaneous Melanoma

Favorite
T1530-02-13 - Development and Characterization of Nanoparticulate Dosage Form to Deliver Anti-cancer Drug Carmustine Across the Blood-Brain Barrier

Favorite
M1530-01-04 - Development and Characterization of Orally Disintegrating Films Loaded with High Levels of Ibuprofen Nanoparticles

Favorite
T1330-02-12 - Development and Characterization of PLGA Nanoparticles for the Delivery of mitoNEET Ligand NL-1 in Stroke Treatment

Favorite
M1530-03-15 - Development and Characterization of Polymeric Films Containing Thymoquinone for the Treatment of Wound Healing and Bacterial Skin Infections

Favorite
W1030-07-49 - Development and Characterization of Sublingual Insulin Film

Favorite
T1230-03-20 - Development and Evaluation of a Micro-dispersed Drug-in-Adhesive Delivery System of 3-fluoroamphetamine

Favorite
T1230-03-21 - Development and Evaluation of Dermatological Formulation with Enhanced In Vitro Drug Release Using Reduced Level of Diclofenac Sodium

Favorite
T1230-01-06 - Development and Evaluation of Sorafenib-Loaded Nanoparticles as Inhalable Drug Delivery Carriers for Treatment of Non-Small Cell Lung Cancer

Favorite
T0930-05-34 - Development and Optimization of Fast Dissolving Buccal Films Loaded with Ketoprofen Nanoparticles Using Box-Behnken Design

Favorite
W1230-03-18 - Development and Optimization of Oil in PEG Cream

Favorite
W0930-07-46 - Development and Stability of an Extraction Resistant Drug Formulation Containing Crosslinked Poly(Acrylic Acid)

Favorite
W1130-06-40 - Development and Validation of a High-Performance Liquid Chromatography (HPLC) Method for the Determination of Formaldehyde and Acetaldehyde Content in Microcrystalline Cellulose Samples

Favorite
W0930-03-20 - Development and Validation of a Novel HPLC-UV Analytical Method and Stability Evaluation of 4-phenylbutyric Acid, an Antidote for Warfare Chemicals

Favorite
M1030-07-48 - Development and Validation of a Sensitive Method for Alkyl Sulfonate Genotoxic Impurities Determination using Gas Chromatography Coupled to Triple Quadrupole Mass Spectrometry

Favorite
T1530-06-38 - Development and Validation of Fast Stability indicating UPLC Method for Quantification of Pseudoephedrine, Dextromethorphan, Triprolidine,Guaifenesin and preservatives present in cough and cold syrups

Favorite
M1230-06-41 - Development and Validation of In Vitro Release Test (IVRT) Method for Ophthalmic Suspensions – A Walkthrough Exercising Regulatory Guidance

Favorite
T1330-06-38 - Development of a Comprehensive GC-MS Headspace Method for the Evaluation of Multiple Antimicrobial Preservatives in Peptide and Protein Formulations

Favorite
M1230-02-08 - Development of a Folate-Decorated, Macrophage-Targeting Nanoemulsion System for HIV Treatment

Favorite
M1130-01-03 - Development of a Functional Polymer with an Environmental pH Responsiveness for Cancer Targeting

Favorite
W1230-03-20 - Development of a Library of Plastics Additives for Identification of Extractables

Favorite
M1330-02-14 - Development of a Lipopolysaccharide Antagonist for the Systemic Treatment of Sepsis

Favorite
T1430-02-12 - Development of a Mechanistic Absorption Model to Bridge Late Stage Formulation for a BCS Class II Drug Candidate

Favorite
T1230-07-49 - Development of a Medicated Chewing Gum Containing Sceletium tortuosum and Process Optimization Utilizing the SeDeM Diagram

Favorite
W1130-07-47 - Development of a Method to Measure the Encapsulation Efficiency of Phenylalanine in Ethylcellulose Microcapsules and Its Use to Determine Efflux of Phenylalanine from the Microcapsules

Favorite
M0930-03-20 - Development of a Novel and Innovative Drug Delivery System for Local Targeting of the Esophagus

Favorite
T1030-07-47 - Development of a Novel In Vitro Model to Predict Risk of Skin-to-Skin Drug Transfer during Transdermal Hormonal Replacement Therapy

Favorite
M1530-07-44 - Development of a Packaging System for a Cell Therapy Product Suitable for Cryogenic Storage by Utilizing Residual Seal Force and Headspace Oxygen Content Analysis

Favorite
W0930-01-05 - Development of a Protein-Free Amphiphilic Lycopodium Spore Microcapsule for Oral Therapeutics Delivery

Favorite
W1230-04-28 - Development of a Solid Self-Emulsifying Drug Delivery System Containing Dutasteride

Favorite
W1030-04-26 - Development of a Solubilised Capsule Formulation Using Co-micronisation and Precipitation Inhibition

Favorite
T1130-05-34 - Development of a Sustained Release Orally Disintegrating Films for Tamsulosin Hydrochloride

Favorite
M1230-05-32 - Development of Abuse Deterrent Formulation for Loperamide Using Hot Melt Extrusion

Favorite
W1030-06-40 - Development of an GMP Automated Platform for API Forced Degradation Studies and Method Linearity

Favorite
W1230-06-38 - Development of an HPLC Method for the Identification of a Disaccharide Counter-ion in the DP Investigation on the Anomalous Behavior of the Disaccharide Standard Solution

Favorite
W1130-05-29 - Development of an In Situ Gel Formulation for the Enhanced Topical Delivery of Niacinamide on Microporated Skin

Favorite
M0930-01-05 - Development of an Inhaled Clofazimine Formulation for the Treatment of Pulmonary Tuberculosis

Favorite
M1230-03-18 - Development of an Ointment-Based Topical Ocular Delivery System for Hydrogen Sulfide

Favorite
M1130-02-13 - Development of Anti-inflammatory Drug-Eluting Polymeric Devices

Favorite
T1430-02-14 - Development of Aprepitant-loaded Phosphatidylcholine Solid Dispersions for Enhancing Dissolution Rates

Favorite
W1130-03-20 - Development of Carboplatin Loaded Liposomes for Pulmonary Delivery

Favorite
T1130-05-31 - Development of Different Density-Controlled Release 3D Printing Tablets Using HME Technologies

Favorite
T1030-01-05 - Development of Eudragit Based Natamycin Films for Ophthalmic Applications Using Design of Experiments Approach

Favorite
M1330-01-06 - Development of Excipient-Free Caveolin-1 Scaffolding Peptide Dry Powder Inhalation for Treatment of Idiopathic Pulmonary Fibrosis – Stability Study

Favorite
T1030-01-04 - Development of High Potency Tacrolimus Dry Powder for Inhalation by Thin Film Freezing

Favorite
T0930-03-16 - Development of Hyaluronidase Sensitive Palm Oil Based Organogel for In Vitro Release of HIV/AIDS Microbicides Using Artificial Neural Networks

Favorite
T1530-07-48 - Development of Implantable Malaria Chemoprophylaxis

Favorite
T1130-02-13 - Development of In Vitro - In Vivo Correlations (IVIVC) Using the Gastro-Intestinal Simulator (GIS)

Favorite
W0930-01-04 - Development of Inhalable Solid Lipid Nanoparticles Formulation by Hot Melt Extrusion Technique

Favorite
T1530-03-19 - Development of iRGD Conjugated Semifluorinated Nanoassemblies for Targeted Drug Delivery to Solid Tumors and Study of the Polymer Architecture Effect to the Delivery Platform

Favorite
M1130-04-22 - Development of Monoacetyldiglyceride (MADG) Loaded Self-emulsifying Granules with Enhanced Oral Bioavailability Using Fluid Bed Granulator

Favorite
M1430-04-27 - Development of Nano-amorphous Spray Dried Powder to Improve Dissolution Rate: Stabilizer Selection and Formulation Optimization Using Quality by Design (QbD) Approach

Favorite
W1030-03-15 - Development of Nanoparticles for the Treatment of Lymphatically Metastasizing Melanoma

Favorite
T1530-07-46 - Development of Novel Bilayer Microarray Patches (MAP) Containing a High Dose of Long-Acting Cabotegravir Nanosuspension as an Alternative to Injectable Delivery

Favorite
T1230-07-43 - Development of Novel Formulations Through 505(b)(2) Pathway Prevailing Over the Regulatory Barriers

Favorite
M0930-02-14 - Development of Oral Solid Dosage Form for Sunitinib Free Base with Improved pH-Dependent Dissolution Rate and Absorption

Favorite
T1530-03-21 - Development of Polyssacharide-Based Nanoparticles for Mucosal Vaccine Delivery Against Group A Streptococcus

Favorite
W1030-04-25 - Development of Rutin smartCrystals^®for Targeted Dermal Application

Favorite
T1230-06-39 - Development of Solution Based Certified Reference Materials for the Analysis of Gabapentin Pharmaceutical Impurities

Favorite
T1130-07-48 - Development of Stability Indicating RP-HPLC Method for an Anthraquinone Botanical Extract in a Topical Formulation for Treatment of Wounds

Favorite
M1330-07-49 - Development of Supersaturable Solidified Self-nanoemulsifying Drug Delivery System to Enhance the Dissolution Rate of a Ketoprofen

Favorite
W0930-02-09 - Development of the Customized Cardiovascular Stent Made from the Biomimetic Hydrogel

Favorite
M1030-07-44 - Development of Transdermal Controlled Release Formulation for Tacrolimus

Favorite
M0930-03-19 - Development of Pediatric Anti-HIV Formulations with Improved Dissolution Characteristics

Favorite
M1430-05-29 - Dexlansoprazole Dual Delayed Release Formulation Using pH Dependent ECOPOL® Polymers

Favorite
M1030-04-22 - Diclofenac Sodium Entrapment Efficiency and Stability in MCM-41 Carrier Which Surface Had Been Amino-Functionalized Using Two Methods

Favorite
M1130-07-45 - Difference in Palatability Among the Formulations of Kremezin®, an Oral Absorbent of Uremic Toxins, in Chronic Kidney Disease (CKD) Patients

Favorite
W1230-02-08 - Different Liposome Classes Interact Differently with Brain Endothelial Cells

Favorite
T0930-06-42 - Differentiating the Effects of Different Oxidative Stress Conditions on Therapeutic Monoclonal Antibodies

Favorite
T1230-04-26 - Direct Powder Extrusion 3D Printing of Itraconazole-Hydroxypropylcellulose Formulations

Favorite
T1530-04-24 - Discovery and Characterization of Novel Solubilizing Excipients via High Throughput Methods

Favorite
M1030-06-37 - Dissolution Behavior of Neutral Drugs in FaSSIF Versions

Favorite
M1330-04-24 - Dissolution Mechanism of Amorphous Solid Dispersions as a Function of Drug Loading: Role of Polymer Hydrophobicity

Favorite
T1130-02-08 - Dissolution Methods for Evaluation of Oral Soluble Films: A Comparison Between USP-2 and a Novel “Basket-in-Tube” Method

Favorite
W0930-04-24 - Dissolution of Indomethacin Crystals into a Polymer Melt: Role of Diffusion and Fragmentation

Favorite
T0930-02-13 - Docetaxel Formulation in Polysorbate 80: A Complex and Sensitive System

Favorite
T1030-04-28 - Double-Layer Coated Solid Dispersion of Aprepitant (SYO-1906) for Enhancing Solubility and Bioavailability without Nanonization

Favorite
W1230-06-37 - Double-Layer Complex Tablets of Tadalafil and Amlodipime to Treat Erectile Dysfuncion and Hypertension

Favorite
W1230-01-06 - Downstream Process Considerations for Industrial Polymeric Submicron Particle Manufacturing

Favorite
M1430-07-49 - Drug Delivery from a Novel Fixed-dose ICS/LAMA/LABA MDI using Co-suspension Delivery Technology: Evidence of Consistency, Robustness, and Reliability

Favorite
M1330-01-03 - Drug Repositioning of Poorly Soluble Drug, Flubendazole via Metastable Salt Formation

Favorite
M1030-02-10 - Drug Supersaturation in Lipid-Based Drug Delivery Systems: Pharmacokinetic Studies with Celecoxib and Cinnarizine

Favorite
M1430-05-35 - Dry Powder Coating of a Novel Polymer for Taste Masking

Favorite
T1530-05-34 - Dry Powder Coating of Guaifenesin for Taste Masking in Orally Disintegrating Tablets

Favorite
T0930-01-02 - Dry Powder Formulation and Characterization of Potential Anti-Tuberculosis Drug CPZEN-45

Favorite
T1330-03-17 - Dry Powder Inhalation System for Non-Viral Gene Editing

Favorite
W0930-02-14 - Dual Functional Oleic Acid Magnetic Nanoparticles – In Vitro In Vivo Model for Glioblastoma Multiforme

Favorite
T1030-03-17 - Dual Neurovascular Targeting Platform for Stroke Based on Platelet-Like Nanoparticles Loaded with Ginkgolide B

Favorite
M1430-07-46 - ɑ_vβ₃-Targeted Liposomal Drug Delivery System with Attenuated Immunogenicity Enabled by Novel Peptides for Glioma Therapy

Favorite
T0930-05-32 - Edible Pyrazinamide-Loaded Orodispersible Hollow-Cup Carrier for Flexible Paediatric Dosing: Design and In Vitro Physicochemical Characterization

Favorite
W1130-05-33 - Effect of % HPO and Particle Size Levels of Hypromellose on the Release of Theophylline Controlled Release Tablets – A Quality by Design (QbD) Approach

Favorite
M1330-05-32 - Effect of Binder Level on Structure and Properties of Acetaminophen-Klucel Granules Prepared Using Continuous Twin-Screw Melt Granulation

Favorite
T1030-05-33 - Effect of Binder Type and Addition Method on Granule Properties in Continuous Twin Screw Wet Granulation

Favorite
T0930-07-45 - Effect of Encapsulated Gas in Microbubbles on Ultrasound-based Drug Delivery for Brain

Favorite
M1330-03-21 - Effect of Ethylene Oxide External Surface Sterilization on Stability of Ranibizumab in Prefilled Syringes

Favorite
M1130-05-34 - Effect of Excipients as Physical and/or Chemical Barriers on Abuse-Deterrent Extended Release Tablet

Favorite
M1230-07-49 - Effect of Formulation and Printing Parameters on Critical Quality Attributes of Printlets Printed by Selective Laser Sintering

Favorite
W1130-01-02 - Effect of Formulation Factors on Stability of Aqueous Solution Containing Pemetrexed

Favorite
M1030-01-05 - Effect of Formulation Variables on IOP Lowering Profiles of Delta⁹-Tetrahydrocannabinol Valine Hemisuccinate Loaded Nanoemulsion in Normotensive Rabbits

Favorite
T1130-03-19 - Effect of Incremental Changes in Surfactant of Semi-solid Topical Product and Its Effect on Performance Attribute

Favorite
T1230-05-35 - Effect of Magnesium Stearate Hydrate Form on Dissolution

Favorite
M1230-05-30 - Effect of Manufacturing Process Parameters on Mechanical Characteristics of Megabeads

Favorite
M1530-03-21 - Effect of Mixing Method as a Processing Parameter on the Adhesive Properties of Suspension-Based Transdermal Patches

Favorite
M1430-06-40 - Effect of Oxygen Level and Temperature on Stability of Lipids

Favorite
T1130-04-28 - Effect of Particle Morphology on the Mechanical Properties of Felodipine in PVP VA64 Spray-Dried Amorphous Solid Dispersions

Favorite
T1430-05-30 - Effect of PEG 400 and Polyvinyl Alcohol (PVA) on the pH-Sensitive Nanoparticles Formation and Stability

Favorite
T0930-06-36 - Effect of Permeation Enhancers on Insulin Solution via Sublingual Administration

Favorite
M1030-01-04 - Effect of pH on the Degradation Rate of Tacrolimus in Cyclodextrin Solution

Favorite
W1230-05-29 - Effect of pH-Modifiers on Solubility and Dissolution Rate of Telmisartan Solid Dispersions by Hot Melt Extrusion Technology

Favorite
M0930-05-30 - Effect of Polymer and Drug Loading on the Drug Release Profile and Solid-State Stability of Anti-Solvent Precipitated Lumefantrine Amorphous Solid Dispersions

Favorite
W1130-01-05 - Effect of Polymer Source Variation on In Vitro Drug Release of Leuprolide Acetate Microspheres

Favorite
M1430-02-13 - Effect of Preparation Temperature and Pore Former on PLGA Microparticles

Favorite
M1330-01-02 - Effect of Salt Form on AR-13503 Polymer System Compatibility and In Vitro Release Kinetics

Favorite
T1330-05-29 - Effect of Solvent on Re-crystallization of BCS Class II Drugs during Strip Film Manufacturing via Solution Casting

Favorite
T1130-01-04 - Effect of Stabilizer on Thermal Stability of Cediranib Maleate/Cyclodextrin Complexes in Aqueous Suspension

Favorite
T1030-05-32 - Effect of Sugar and PEG on Helix Stabilization of Alanine Based Peptides

Favorite
M1130-01-04 - Effect of Surfactant and Surface Coating Material on the Physicochemical Properties of Pimozide Nanoparticles

Favorite
T0930-03-20 - Effect of the Addition of Sodium Chloride and Sodium Citrate in Some Attributes of Soft Gelatin Capsules

Favorite
T1030-05-31 - Effects of Binder and Concentration of Polyethylene Oxide on the Mechanical Properties of Abuse Deterrent Formulations

Favorite
W1130-02-11 - Effects of Co-solvents on the Properties of Goserelin-Loaded PLGA Microsphere

Favorite
W1130-04-27 - Effects of Drying Temperature and Particle Size Control on Downstream Performance of Spray Dried Regorafenib/HPMCAS System Dissolved in Tetrahydrofuran (THF)

Favorite
W1030-02-13 - Effects of Fatty Acid Composition in Polysorbate on Biotechnology Drug Product Quality

Favorite
T1330-04-28 - Effects of Labrasol and Its Related Formulations on the Intestinal Absorption of Insulin and Elucidation of Their Absorption Enhancing Mechanisms

Favorite
W1030-07-43 - Effects of Microstructure on Lidocaine-Prilocaine Topical Product Performance

Favorite
T1130-05-33 - Effects of Processing and Formulation Variables on the Abuse-Deterrent Properties of PEO-Matrix Tablets

Favorite
M1430-07-47 - Effects of Sugar Blending on Mechanical Properties of the Dissolving Microneedles

Favorite
T1330-07-48 - Effects of Synthesis Parameters on Formation and Property of Thermo-Responsive Injectable Hydrogel Scaffolds for Stem Cell Engineering

Favorite
W0930-04-23 - Effects of Temperature and Ionic Strength of Dissolution Medium on Charge-Assisted Bond N⁺-H Mediated Gelation of Amorphous Lurasidone Hydrochloride

Favorite
W1130-01-04 - Efficacy of Ethanol Injection as a Low Temperature, Mechanical Shear Stress-free Method to Prepare Docetaxel-Folate-Targeted Liposomes

Favorite
M1130-02-14 - Efficient Cell Growth Inhibition Using Interferon-β pDNA Complexes of a Novel Phosphorylcholine-Based Polymer for Glioblastoma Therapy

Favorite
T0930-02-12 - Efficient Nanog Knockdown by Novel Ternary siRNA Complexes for Acute Myeloid Leukemia Therapy

Favorite
T1530-07-47 - Engineering 3d Printed Non-Viral Gene Delivery System for Bone Regeneration

Favorite
M1430-02-09 - Engineering of Piroxicam Loaded Polymer Hybrid Microspheres: Development, Characterization and In Vivo Evaluation

Favorite
T1330-04-25 - Enhanced Dissolution of Ibuprofen by Nonpareil Beads Containing Solubility Enhancers

Favorite
M1230-04-24 - Enhanced Oral Bioavailability of Paclitaxel by Self-Microemulsifying Drug Delivery System: Formulation Development, In Vitro and In Vivo Evaluation in Rabbits

Favorite
T1530-03-16 - Enhanced Subcellular Trafficking of Resveratrol Using Mitochondriotropic Liposomes in Cancer Cells

Favorite
T0930-07-47 - Enhanced Topical Delivery by a Microcurrent Generating Device

Favorite
T1130-03-17 - Enhanced Transdermal Delivery of 4-Phenylbutyric Acid– A Chemical Chaperon Effective Against Vesicant Warfare Chemicals

Favorite
M1230-04-26 - Enhancement of Aqueous solubility of Hispolon by Complexation with Sulfobutylether-β-Cyclodextrin

Favorite
W1230-03-17 - Enhancing the Delivery of Ibuprofen Through the Skin Using In Silico Modeling

Favorite
M1130-04-24 - Enhancing the Intestinal Permeability of Fenretinide Using Milk Derived Exosomes

Favorite
W1130-02-12 - Estimating Excipient Effect on Dissolution Profiles of Solid Solutions Using DDDPlus^TM

Favorite
M1130-07-49 - Eutectic Mixtures of Celecoxib with Adipic Acid/Saccharin: Improved Dissolution Rate and Wettability

Favorite
M0930-01-03 - Evaluating the Batch to Batch Reproducibility and Aerosol Performance of Spray Dried Albuterol Sulfate Formulations Using Cascade Impaction and Laser Diffraction Methods

Favorite
M1130-07-44 - Evaluating the Potential of Drug Eluting Contact Lenses for Treatment of Bacterial Keratitis Using an Ex Vivo Corneal Model

Favorite
M1130-05-32 - Evaluation of a New Grade of Highly-Compressible Methylcellullose for Direct Compression

Favorite
T1330-06-41 - Evaluation of an Automated, Acidic pH Protein Digestion for Reduced Levels of Artificial Deamidation in Biotherapeutic Peptide Mapping Studies

Favorite
M1530-07-48 - Evaluation of an Immediate-Release Formulation of Hydroxychloroquine Sulfate with an Interwoven Pediatric Taste-Masking System

Favorite
M1230-06-37 - Evaluation of Degradation Products of Insulin using High Resolution Mass Spectrometry with Proteome Discoverer and BioPharma Finder

Favorite
M1030-07-45 - Evaluation of Different Suppliers of Ethylene Vinyl Acetate Used in Intravaginal Rings

Favorite
T1530-04-28 - Evaluation of Distribution and Anticancer Activity of Conformational Switch-Based, pH-Sensitive Liposomes in 3D Multicellular Spheroids

Favorite
M1030-05-33 - Evaluation of Hot Melt Extruded Caffeine Pellets Containing POLYOX™ Water Soluble Resins

Favorite
T1430-06-39 - Evaluation of Influence of Pediatric Gastrointestinal Fluid Composition and Volume on Dissolution and Solubility of BCS II Drug

Favorite
W1130-05-32 - Evaluation of Instacoat CFC Formulation (Sugar Free) Using Chewing Gums

Favorite
W0930-05-32 - Evaluation of Instanute MB II, a Label Friendly High Solids Moisture Barrier Film Coating Formulation on Multivitamin Multimineral Tablets

Favorite
T0930-02-11 - Evaluation of Lansoprazole Enteric Hard Capsule Encapsulated by Sodium Alginic Acid

Favorite
W1130-02-10 - Evaluation of Metformin Tablet Using Wet granulation for Sustained Release

Favorite
T0930-03-19 - Evaluation of Metronidazole Bioavailability from Dermal Products Using an In Vitro Permeation Test (IVPT) Across Human Skin

Favorite
T0930-05-29 - Evaluation of Partially Pregelatinized Starch in a Continuous High Shear Wet Granulation Process

Favorite
T1330-03-20 - Evaluation of Quantitative Capsule Rupture Test Methods and Data Variability in Generic Omega-3 Capsule Applications

Favorite
T1430-05-35 - Evaluation of Taste Masking Efficiency of Kollicoat® Smartseal 100P Using Hot Melt Extrusion Techniques

Favorite
W1030-05-32 - Evaluation of Xanthan/ Locust bean blend Fluid Gels as Modified Release Oral Liquids

Favorite
T1430-03-17 - Ex Vivo Transport Study on Quercetin−Cyclodextrin Inclusion Complexes as Candidates for Nose−to−Brain Delivery

Favorite
M0930-02-08 - Excipient Similarity in Generic Formulations Containing Biopharmaceutics Classification System 3 Drugs

Favorite
M1130-02-10 - Exploitation of Coarse Black Phosphorus Using Plug-and-Play Technique for Inducing Chemo-Photo-Immunotherapy Against Colorectal Cancer

Favorite
M1530-04-22 - Exploratory Study of Aripiprazole-Adipic Acid Co-crystals by Hot Melt Extrusion Technique for Improved Solubility and Dissolution Rate

Favorite
M0930-06-40 - Exploratory In Vitro Mastication to Assess the Potential Accelerated Release of Fentanyl from a Transdermal Patch

Favorite
W0930-06-37 - Exploring Factors Affecting Nifedipine Biphasic Dissolution Profile Using an inForm Platform

Favorite
T1030-04-25 - Exploring Precipitation Inhibitors in Supersaturated Lipid-Based Formulations: Case Study Venetoclax

Favorite
T1230-05-31 - Exploring the Development of an Anhydrous Substitute for Petrolatum

Favorite
T1130-06-42 - Exploring the Physical Stability of Amorphous Drugs - The Thermodynamic Toolbox

Favorite
T0930-05-31 - Exploring the Role of Synbiotics as Carrier to Solidify Self Nano-emulsifying Drug Delivery System

Favorite
M1230-01-02 - Extending Shelf-Life of Therapeutic Proteins, Part 1: Arresting Rate of Aggregation during Agitation and Thermal Stress Using IgG as a Model Protein

Favorite
T1230-01-02 - Extending Shelf-Life of Therapeutic Proteins, Part 2: Reverting Reversible Aggregates into Monomers and Arresting Rate of Aggregation of Bevacizumab

Favorite
M1530-07-47 - Extractable Assessment of Blood Glucose Test Strips and Lancing Devices

Favorite
T1430-07-47 - Extremely Low Molar Ratio Captisol-Enabled Kidney Protective Iohexol Formulations – Comparative Cardiovascular Assessment in Anesthetized Male Dogs following Rapid Intracoronary Injection

Favorite
W1030-05-34 - Fabrication of Immediate Release Tablets via Fused Deposition Modeling 3D Printing Paired with Hot-Melt Extrusion

Favorite
W1130-07-49 - Fabrication of Shell-Core Delayed Release Tablet Using Dual Nozzle Fused Deposition Modeling 3D Printing Techniques

Favorite
T1530-01-07 - Factors of Bitterness in Clinical Medicines for Pediatric Patients Evaluated by Correlation between Physicochemical Properties or Biopharmaceutics Classification and Taste Sensor Responses

Favorite
T1030-06-39 - Factors to Consider During Filter Validation in Pharmaceutical QC

Favorite
M1130-04-25 - Fasted and Fed Bioequivalence Studies of SYO-1644 (Sorafenib Bioavailability Enhanced Tablets) in Beagle Dogs

Favorite
M1130-07-43 - FDA Draft Guidance, Use of Liquids and/or Soft Foods as Vehicles for Drug Administration – Why are Composition and Physicochemical Properties Important for Compatibility and Suitability Studies?

Favorite
T0930-03-18 - Film Forming Polymeric Solutions as Drug Delivery Systems for the Transdermal Delivery of Drugs

Favorite
T1230-05-30 - Fine Engineered Excipients for Improving the Disintegration and Dissolution Behaviors for BCS II Drugs

Favorite
W1130-07-46 - FITC Dextran Loaded PLGA Microneedles for Its Application in Transdermal Drug Delivery

Favorite
M1130-05-29 - Flow Behavior of the Cross-Linked Acrylic Acid Polymers Commonly Used in the Pharmaceutical Dosage Forms

Favorite
T1130-05-32 - Fluid Bed Coating of Microparticles: Effects of MicroCoat Technology on Drug Release

Favorite
T1530-06-39 - Fluoride in OTC Products by Ion Chromatography

Favorite
M1530-03-18 - FMX101 4% Topical Minocycline Foam: Drug Delivery into the Pilosebaceous Follicles, Sebum Softening Effect and Bacterial Susceptibility

Favorite
T0930-03-21 - Formation of Kollidon® VA-64 Based Theophylline Nicotinamide Co-crystals Utilizing Hot Melt Extrusion Technology

Favorite
M1230-03-21 - Formulating Pediatric Taste Masked Multiparticulates Using CPS^TM Technology

Favorite
M1430-01-01 - Formulating Aerodynamically Equivalent pMDIs for Determining the Effect of Non-volatile Excipients on Aerosol Particle Dissolution

Favorite
M1530-02-13 - Formulation and Characterization of a Degradable Drug Eluting Implant Coating for Improved Osseointegration

Favorite
W0930-01-03 - Formulation and Characterization of Intranasal Microemulsions of Mebendazole: An Alternative Approach for Glioblastoma Multiforme Treatment

Favorite
W0930-03-19 - Formulation and Characterization of Nanostructured Lipid Carriers Containing Rivastigmine Hydrogen Tartarate for the Management of Alzheimer’s Disease

Favorite
M1230-02-11 - Formulation and Evaluation of Afatinib Loaded PLGA Nanoparticles for Metastatic Non-Small Cell Lung Cancer

Favorite
M1030-04-27 - Formulation and In Vitro Evaluation of Self Microemulsifying Drug Delivery System (SMEDDS) for Oral Delivery of Plumbagin

Favorite
T1430-01-05 - Formulation and Optimization of Delta 9 -Tetrahydrocannabinol- Valine-Hemisuccinate (THC-VHS, NB1111) Loaded Nanoemulsion

Favorite
W1030-02-11 - Formulation and Pharmacokinetic Study of Ibuprofen Nanoformulations

Favorite
W1230-07-49 - Formulation by Design^®: A Novel Lego Approach for Predictable In Vivo Pharmacokinetic Profile Using 3D Printing Technology

Favorite
M1430-01-03 - Formulation Development and Characterization of Paclitaxel Loaded Nanostructured Lipid Carriers for the Treatment of Retinoblastoma

Favorite
M1230-04-23 - Formulation Development and Cytotoxicity Evaluation of Self-Emulsifying Drug Delivery System (SEDDS) containing Long-Chain Fatty Acid for Oral Delivery of Poorly-Soluble Drugs

Favorite
T1030-02-13 - Formulation Development for a Labile Bi-specific Protein

Favorite
M1430-04-24 - Formulation Development of Amorphous Solid Dispersions by Hot Melt Extrusion for a Poorly Soluble Calcium Channel Blocker

Favorite
M1330-07-45 - Formulation Development of Curcumin-Piperine Solid Dispersion via Hot-Melt Extrusion to Enhance Solubility and Bioavailability of Curcumin

Favorite
T1330-05-32 - Formulation Development of Fenofibrate Using Twin Screw Melt Granulation

Favorite
T1430-01-07 - Formulation Development, Optimization and Characterization of a Fluoroquinolone Antibiotic Loaded Nano-lipid Carriers for Ocular Applications

Favorite
M1530-05-29 - Formulation of a Metoprolol Succinate Extended Release Tablet with INSTAMODEL® Blend

Favorite
T1430-05-32 - Formulation of a Modified Release Dipyridamole Product, Equivalent to Reference Listed Drug (RLD) Aggrenox from Boehringer Ingelheim Using Tartaric Acid Pellets

Favorite
M1430-03-15 - Formulation of Acyclovir and Lidocaine Topical Gels for Herpes Simplex Virus Infections

Favorite
M1230-05-29 - Formulation of Glimepiride Immediate Release for Anti-diabetes Bilayer Tablets Using Design of Experiments

Favorite
M0930-07-46 - Formulation of Lipid Multi-Particulates – Part 1: Evaluation of Melt-Spray Congealing and Direct Injection for Targeted Product Profile Using Science and Engineering Approach

Favorite
T0930-05-30 - Formulation of Megabeads: A Novel Oral Dosage Form

Favorite
W1230-04-23 - Formulation of Peptide Loaded Layer-by-Layer Nanoparticles Targeting PepT1 Intestinal Transporters: A New Strategy for Oral Peptide Delivery

Favorite
W1230-01-07 - Formulation of Rivastigmine, a Liquid Drug Substance, for Use in Hollow Microstructured Transdermal Delivery System

Favorite
T1330-05-30 - Formulation, Evaluation, and Improvement of Meloxicam Oral Disintegrated Tablets Using Design Expert^® and Six Sigma

Favorite
T0930-07-43 - Formulation, Evaluation, and Pharmacokinetic Study for Telmisartan Cubosomal Based Oral Tablet in Rabbits

Favorite
T1530-05-30 - Formulation, Evaluation, and Pharmacokinetic Study for Telmisartan Proniosomal Based Oral Tablet in Rabbits

Favorite
M1130-06-42 - Free siRNA Quantitative Analysis Method Development by Size Exclusion Chromatography (SEC)

Favorite
T1130-07-44 - Fully Automated Determination of pH Using Flow Cell Technology

Favorite
M1530-04-25 - Fundamental Evaluation and Characterization of Etoricoxib Solid Dispersions Prepared by Spray Drying

Favorite
W1130-04-24 - Gastrointestinal Stability of Solubility-Enhanced Ezetimibe and Simvastatin Formulations

Favorite
W1230-04-26 - Gelucire 48/16^® for Type-IV Lipid Based Formulations and Their In Vitro In Vivo Performance Evaluation

Favorite
M1030-03-18 - Glabridin smartLipids for Skin Whitening Products – Optimization of Formulation and Production Parameters

Favorite
W1230-07-44 - Glucose Transporter -1 Targeting Liposomal Nanoparticles for Efficient Gene Delivery Across In Vitro Triple Co-Culture Blood Brain Barrier Model

Favorite
W0930-01-06 - Gold-Nanoparticles Coated with the Antimicrobial Peptide ε-Polylysine Dry Powders as an Inhalable Strategy for Local Therapy of Pulmonary Infection

Favorite
M1230-02-13 - Heparin-based IL-12 Complex Coacervate Inhibits B16F10 Melanoma Tumor Progression

Favorite
W1230-02-09 - High Throughput Manufacture of Doxorubicin Loaded PEGylated Liposomes

Favorite
T1430-01-03 - High-Density Lipoprotein Nanoparticles Delivering Liver X Receptors Agonist for the Treatment of Age-related Macular Degeneration

Favorite
W1130-03-16 - High-Throughput 3D Bioprinting of Corneal Equivalents for a Realistic Blinking Eye Perfusion Model

Favorite
T1430-04-26 - High-Throughput Formulation Screening to Enable Early Discovery Activities for Poorly Soluble Compounds

Favorite
W1030-06-38 - Holistic Analytical Characterization of Residual Host Cell Protein Impurities in Pharmaceutical Process Development toward a Knowledge-Based Risk Control Strategy

Favorite
T1030-02-08 - How Broadly Can Poly(urethane)-Based Implants be Applied to Drugs of Varied Properties?

Favorite
M1030-04-26 - How to Enhance the Intestinal Permeability of the Peptide Leuprorelin?

Favorite
W0930-02-10 - HPC Molecular Weight Impact on the Drug Solubility of Dry Nano-Suspensions

Favorite
T1030-07-48 - HPMCAS-based Amorphous Solid Dispersion containing Surfactant Prepared via Hot-melt Extrusion: Effects of Different HPMCAS grades and Particle Size of Extrudates on Drug Release and Supersaturation

Favorite
T1330-06-42 - HR Multi-Attribute Method for Critical Quality Attribute Monitoring and New Peak Detection

Favorite
M1530-02-11 - Human Serum Albumin: Drug Delivery Template Targeting Breast Cancer Cells

Favorite
T1230-02-10 - Hyaluronic Acid Modified Mesoporous Titania Nanoparticles for Target Delivery of Doxorubicin

Favorite
M1030-02-09 - Hyaluronic Acid Targeted, Dual Drug Loaded, Mixed Nanomicelles for the Treatment of Breast Cancer

Favorite
W1130-04-22 - α- tocopherol Loaded PLGA Nanoparticles for the Treatment of Spinal Cord Injury

Favorite
T1130-02-11 - Identification of a Clinically Relevant Dissolution Method of EGb 761 Tablet for Better Correlation with Its In Vivo Pharmacokinetics

Favorite
W1130-06-38 - Identification of Extractables and Leachables from Pharmaceutical Containers by Raman Microscopy

Favorite
T1430-02-09 - Identification of Potential Formation Causes of Adverse Effects Caused by Tablet Product Brand-Switching of Warfarin Using PBPK/PD Modeling

Favorite
W1030-01-04 - Illustrative and Predictive Tools: Isothermal Calorimetry Combined with Molecular Modelling for the Study of Cyclodextrin/Drug Interactions

Favorite
T1030-04-24 - Imidazole-Based pH-Sensitive Convertible Liposomes - Turning Stealth Liposomes into Cationic Liposomes for Anticancer Drug Delivery

Favorite
M1430-03-20 - Impact of Critical Formulation Variables on a Nano-Lipid Cannabidiol Formulation

Favorite
T1230-04-27 - Impact of Drug Loading on Compaction Properties of Itraconazole-PVPVA Amorphous Solid Dispersions

Favorite
T1430-03-20 - Impact of Drug-Polymer Hydrogen Bonding Interaction on the Initial Drug and Polymer Release from Tableted Amorphous Solid Dispersions

Favorite
W1130-05-31 - Impact of Formulation Components on Physical Properties of Mini-tablets

Favorite
T1430-02-11 - Impact of HPC Chain Length on the Supersaturation of Itraconazole

Favorite
T1230-04-23 - Impact of Incorporated APIs on Material Properties of Hot-Melt Extruded Amorphous Solid Dispersions

Favorite
W1130-01-06 - Impact of Manufacturing Processes on Critical Quality Attributes of Brinzolamide Ophthalmic Suspensions

Favorite
M0930-05-31 - Impact of Milling on the Evaluation of Abuse-Deterrent Formulations

Favorite
M1330-04-25 - Impact of Polymeric Carriers on the Processability of Theophylline Nicotinamide Pharmaceutical Co-crystals Utilizing Hot Melt Extrusion Technology

Favorite
W1030-05-29 - Improved Extended Release Highly Loaded Drug Compositions Using Carbopol^® Polymers in Combination with Suitable Microenvironmental pH Modulators

Favorite
T1530-06-42 - Improved Middle-Down Characterization of Antibodies Using Multiple Ion Activation Techniques and Proton Transfer Reaction on a Modified Orbitrap Mass Spectrometer

Favorite
M1530-06-40 - Improved Osmium Recovery for USP < 232 > Assessments

Favorite
M1530-03-20 - Improvement of In Vitro Skin Penetration Method via Modified Skin Penetration Model (MSPM)

Favorite
M1330-04-22 - Improving Mechanical Properties of Crystalline β-Mannitol by Cocrystallization with Calcium Chloride

Favorite
M1130-04-28 - Improving Oral Drug Absorption – Which Technology to Select? A Spray-Dried Dispersion and Lipid-Based Formulation Case Study Using Abiraterone Acetate

Favorite
M1130-03-15 - Improving Side Effect and Efficiency of Omeprazole Using Oral Thin Film In Vitro Evaluation

Favorite
W1130-04-26 - Improving Solubility and Oral Bioavailability of a Novel Anti-malarial Prodrug: Comparing Spray-Dried Dispersions with Self-emulsifying Drug Delivery Systems

Favorite
W1230-04-27 - Improving the Aqueous Dissolution Behavior of Ursolic Acid and Curcumin Utilizing an Enhanced Amorphous Solid Dispersion Technique

Favorite
M1530-04-23 - In Situ Crystal Growth Rate Distributions Enabled by Single Particle Tracking

Favorite
W1030-01-01 - In Situ Crystallisation of Propranolol Salts in an Amorphous Polymeric Matrix Made of Soluplus®

Favorite
T1430-01-04 - In Situ Gel of Cyclosporine a Loaded Solid Lipid Nanoparticles for Topical Occular Delivery in Dry Eye Disease

Favorite
T1430-02-08 - In Situ Rheological Measurements of the Gellan Gum Fluid Gel

Favorite
T1530-05-32 - In Situ Stablisation of Fluid-Bed Coating Process of Sustained Release Microparticles: Reduction in Particle Cohesion

Favorite
W1030-01-02 - In Vitro µFlux Studies to Understand the Impact of HPßCD Concentration on Exposure in Rat Species

Favorite
T1230-03-15 - In Vitro and Ex Vivo Stability and Permeation of Acetylsalicylic Acid (Aspirin®) in View of Its Nose-to-Brain Delivery in CNS Disorders and Cancer

Favorite
M1130-03-18 - In Vitro and In Vivo Assessment of a Novel Immediate Release Abuse Deterrent Dextroamphetamine Formulation

Favorite
W1230-05-32 - In Vitro and In Vivo Assessment of the Potential of Supersaturation to Enhance the Absorption of Poorly Soluble Basic Drugs

Favorite
T1130-03-18 - In Vitro and In Vivo Evaluation of Transdermal Absorption of Solifenacin Succinate in Cream and Tape Formulations

Favorite
W1130-01-01 - In Vitro and In Vivo Evaluation of PLGA In Situ Implant and Nanoparticles Sustained Injectable Formulations of Entecavir

Favorite
M1530-02-14 - In Vitro Anti-cancer Evaluation of Paclitaxel/Alpinumisoflavone Co-loaded Micelles

Favorite
M1530-03-17 - In Vitro Artificial Multilayer Skin Model to Study Rate of Drug Transport

Favorite
M1230-07-45 - In Vitro Assessments of Nasal Discomfort Caused by Abuse Deterrent Formulations

Favorite
T1430-06-40 - In Vitro Biphasic Dissolution Test: A Study of Excipient and Manufacturing Variables

Favorite
T1030-03-15 - In Vitro Characterization and Targeted Delivery of Hydroxyethyl Starch-Polyethyleneimine Based Polyplexes Using a Transferrin Receptor Antibody (8D3)

Favorite
W1030-04-28 - In Vitro Dissolution and Pharmacokinetic Studies of Aceclofenac Immediate Release Tablets Incorporating Its Inclusion Complex with Hydroxypropyl-β-Cyclodextrin

Favorite
T1430-06-37 - In Vitro Dissolution of a Weak Basic Drug in Standard Biorelevant Media and Media Representing PPI Co-administration

Favorite
T1430-07-46 - In Vitro Evaluation and Stability of the Deterrence Performance of Dextromethorphan HBr-AcDiSol^® Complex Tablets

Favorite
T1030-04-23 - In Vitro Evaluation of Leuprolide-Containing Solid Lipid-Based Nanosuspensions: Ability to Encapsulate, Release, Protect, and Permeate in the Gastrointestinal Tract

Favorite
M1130-07-48 - In Vitro Investigation of Regional Nasal Drug Delivery using Two Glucocorticoid Nasal Spray Products and Twenty Anatomical Nasal Replicas

Favorite
M0930-07-49 - In Vitro Micro-dissolution Testing as an Efficient Predictive Tool for the Development of Suspension Type Lipid-Based Formulations

Favorite
M0930-06-41 - In Vitro Release Testing of PLGA Nanoparticles Using Flow-Through Cell USP-4 Apparatus

Favorite
T1330-07-49 - In Vitro, Ex Vivo, In Vivo Studies of Insulin Permeability Enhancement by the Use of Microcontainers

Favorite
T1330-03-15 - In Vitro and In Vivo Studies of Dibenzoylmethane (Hydrophobic) and Oxytocin (Hydrophilic) Formulations for Intranasal Delivery

Favorite
M1430-01-05 - In Vivo and Ocular Pharmacokinetic Evaluations of Ophthalmic Gelling Formulations Containing Natamycin Loaded PEGylated Nanolipid Carriers

Favorite
T1030-06-36 - In Vivo Drug Dissolution in Human Oral Cavity from Orally Disintegrating Tablet and Comparability with In Vitro

Favorite
T0930-01-05 - In Vivo Evaluation of Inhalable Sildenafil Citrate-Loaded Hydrogel Microparticles in Comparison to Orally Administered Viagra^® for the Treatment of Pulmonary Arterial Hypertension

Favorite
T1430-07-45 - In Vivo Modulation of Dendritic Cells by a Dual Nanogel System for Immunotherapeutic Treatments

Favorite
W1230-02-13 - Incorporation of a Well Absorbed Marker Compound to Help Understand the Absorption of a Macromolecule from Oral Solid Dosage Forms

Favorite
T1430-01-02 - In-Depth Characterization of Novel Long-Acting Glaucoma Eye Drops

Favorite
W1130-06-36 - Individual pK_a Values of Aminoglycosides Determined by Multinuclear NMR Spectroscopy

Favorite
W1230-02-11 - Induction of Apoptosis by Doxorubicin Conjugated to Gelatin and Comparison to Unconjugated Doxorubicin in Human Breast Cancer Cells

Favorite
M0930-04-24 - Influence of Hydrate Form on the Preparation of Carbamazepine Amorphous Solid Dispersions by Hot Melt Extrusion

Favorite
T1530-04-25 - Influence of Milling Process on Hot Melt Extruded Amorphous Solid Dispersion

Favorite
M1430-05-30 - Influence of Poloxamer on the Dissolution and Stability of Hot Melt Extrusion Based Amorphous Solid Dispersion Using Design of Experiments (DoE)

Favorite
W1030-07-45 - Influence of Relative Humidity on Time to Break Analysis of Pharmaceutical Foams

Favorite
M1130-03-16 - Inhibition of Indomethacin Nucleation and Crystal Growth by Polymers from Supersaturated Solutions

Favorite
T1330-03-16 - Inhibition of Indomethacin Nucleation and Crystal Growth by Polymers from Supersaturated Solutions

Favorite
T1230-02-08 - Injectable In Situ Gelling Metronidazole System for Treating Jawbone Infections

Favorite
M1330-02-12 - Injectable Poly(lactic Acid) Core-Shell Structured Microspheres for 3-6 Month Controlled Release of Etonogestrel

Favorite
M1330-06-42 - In-Line Monitoring of Biocompatible Polymer Film Thickness via Near-IR Spectroscopy

Favorite
M1330-06-41 - In-line Monitoring of Critical Quality Attributes (CQAs) of Thin Drug-loaded Films via Raman Spectroscopy

Favorite
W1130-02-14 - Insight into Molecular Mechanisms Governing the High Concentration Behaviors of a Bispecific Antibody

Favorite
M0930-05-34 - Insights into the Thermal Properties and Freeze-Drying of Hydroxypropyl-beta-Cyclodextrin Formulations

Favorite
T1030-06-38 - Integrating Lattice Boltzmann and Bonded Particle Models to Simulate Tablet Disintegration and Dissolution

Favorite
W1130-06-42 - Intelligent Peak Deconvolution Analysis for Photodiode Array Detector

Favorite
M1430-06-37 - Interaction Between DKP Cyclization and Maillard Reactions in Quinapril Tablets

Favorite
T1030-01-03 - Intraocular Delivery of Triamcinolone Acetonide Protransfersome Gel by Trans-Eyelid Application for Improved Delivery

Favorite
T1330-06-40 - Introduction of a Novel Labelling Strategy to Facilitate LC-MS Analysis of Released N-glycans

Favorite
M1130-05-35 - Investigating role of Lactose particle size, disintegrant concentration & Manufacturing method on the finished product performance of selected BCS class I & IV drug

Favorite
W1130-06-37 - Investigating Species-Dependent Surface Properties of Albumins Using Inverse Gas Chromatography

Favorite
W1230-01-05 - Investigating the Effect of Protein-Excipient Ratios on Lyophile Stability and Robustness

Favorite
M1230-03-20 - Investigating the pH-dependent dissolution behavior of ketoconazole using a microscale medium/pH-shift in vitro model

Favorite
W0930-06-39 - Investigating the Release of Ibuprofen from Three Nurofen® Formulations Using the Dynamic Gastric Model (DGM)

Favorite
T1430-05-31 - Investigating the Tunability of Poloxamer 407 and Poloxamer 338 Gels

Favorite
T1030-05-34 - Investigation of Different Viscosity Grade Polymers for Development of Hot Melt Extruded Filaments for 3D Printing

Favorite
T1130-04-22 - Investigation of Dissolution Performance of Itraconazole Amorphous Solid Dispersions Using HPMCAS -L, -M and -H Grades

Favorite
M1430-05-34 - Investigation of Ion Exchange Resin Complexation Approach for Pediatric Dosage Form of Non-Ionic Drug

Favorite
M0930-01-02 - Investigation of Pharmacokinetic Sensitivity to Regional Lung Deposition of Locally-Acting Orally Inhaled Drug Products

Favorite
M1430-04-26 - Investigation of Possible Solubility and Dissolution Advantages of Cocrystals: Aqueous Solubility and Dissolution Rates of Ketoconazole and its Cocrystals as Functions of pH

Favorite
W0930-05-34 - Investigation of the Solubility Enhancement Potential of Kollicoat® Smartseal 100P Using Hot Melt Extrusion Techniques

Favorite
W1130-06-39 - Iodide Assay by Ion Chromatography

Favorite
W1230-06-39 - Isolation of Individual Isomers from Compounds with Multiple Chiral Centers

Favorite
M1430-06-39 - Isolation of Pharmaceutical Degradations using Supercritical Fluid Chromatography (SFC)

Favorite
W1030-06-36 - Isolation, Solid State Characterization and Evaluation of Digitaria exilis Starch as Excipient in Formulation

Favorite
M1130-01-01 - IV Infusion In-Use Compatibility of the Regulatory Hormone Melatonin

Favorite
T1130-07-45 - L-cysteine and l-serine Modified Dendrimer with Multiple Reduced Thiols as a Kidney-Targeting Reactive Oxygen Species Scavenger to Prevent Renal Ischemia/Reperfusion Injury

Favorite
T1130-04-24 - Leveraging Amorphous Solid Dispersion Development in an Integrated API to Tablet Pipeline

Favorite
M1430-07-43 - Ligand-Modified Cell Membrane Enables Targeted Delivery of Drug Nanocrystals to Glioma

Favorite
W1230-04-25 - Lipid Architectonics for AIDS Therapeutics and Intervention: Formulation Development and In Vitro Assessment

Favorite
W1030-03-18 - Lipid Nanocapsules for the Encapsulation of Piperine

Favorite
M1130-02-12 - Lipid-Polymer Nanoparticle for Intracellular Staphylococcus Aureus Treatment and Biofilm Eradication

Favorite
T1030-02-11 - Lipiodol-Based Emulsions Used for Drug Delivery in Liver Cancer: Effects of Composition on Stability and Product Quality

Favorite
M1130-03-19 - Liposomes as Carriers for the Delivery of Efavirenz in Combination with Glutathione – A Novel Approach to Combat Opportunistic Infections

Favorite
T1530-02-08 - Liquid Crystals: A Sustained Release Platform for Fenretinide Delivery to Prevent Breast Cancer Development

Favorite
M1430-06-38 - Long Term Stability and Impurities Identification of a Novel Transdermal Formulation for E/Z-Endoxifen

Favorite
T1330-02-09 - Long-Acting Hydrogel Formulation of Novel Bupivacaine Salts for Oral Mucositis Pain Control

Favorite
T1230-02-11 - Long-Term Glycemic Control and Prevention of Diabetes Complications In Vivo Using Oleic Acid-Grafted-Chitosan-Zinc-Insulin Complexes Incorporated in Thermosensitive Copolymer

Favorite
T1530-06-36 - Low-Frequency Raman Mapping and Multivariate Image Analysis for Characterization of Complex Pharmaceuticals

Favorite
T1130-02-14 - Low-in-Nanoparticulate-Impurities Sucrose for Biopharmaceutical Formulations

Favorite
T1330-01-04 - Lyophilized Protein Formulation: Factors Affecting Process Efficiency and Product Quality

Favorite
M1430-04-28 - Mangiferin Loaded Nanocapsules: Preparation and Optimization

Favorite
W1230-04-22 - Mangiferin-Phospholipid-Complex (MPC) in Self-assembled Nanoparticles for the Enhancement of Biopharmaceutical Properties of Mangiferin

Favorite
T1130-03-16 - Matrix Transdermal Patches: Manufacturing When Interchanging Active Pharmaceutical Ingredients

Favorite
W1130-04-23 - Maximizing the Therapeutic Potential of Abiraterone through Bioavailability Enhancement

Favorite
T0930-06-39 - Measuring Moisture Content of Lyophilized Product by Near-Infrared Spectroscopy

Favorite
M1230-01-06 - Mechanistic Characterization and Immunological Profile of Thin Films Suitable for Global Immunization Campaigns

Favorite
T1130-01-03 - Mechanistic Investigation of Accelerated Drug Recrystallization in Amorphous Solid Dispersion Triggered by Magnesium Stearate

Favorite
T1130-04-23 - Mechanochemical Synthesis of a Multicomponent Complex Containing Albendazole and Maleic Acid for Improved Physiochemical Properties

Favorite
T1430-03-16 - Membrane Permeation and Efficacy of Vitamin Nanoemulsions

Favorite
W0930-04-27 - Mesoscopic Confinement of a Crystalline Drug into Micronized Synthetic Silica Gels by Solvent Impregnation Method

Favorite
T1030-06-41 - Method Development for the Dissolution of Spray Dried API Tablets

Favorite
T1030-06-42 - Methods for Dissolution Testing of Surface-Eroding Long-Acting Implantables

Favorite
M1430-05-31 - Methods for the Development of Ivermectin and Praziquantel Granulations with Differing Release Rates

Favorite
T0930-02-09 - Microemulsion Concentration Influences the Mechanical Properties and Drug Release Rate of Ibuprofen In Situ Gels

Favorite
T1430-07-49 - Microfluidic Assembly of Lipid Nanoparticles for the Delivery of Antisense Oligonucleotides to Human Pancreatic Cancer Cells

Favorite
W1130-02-08 - Microfluidic PLGA Nanoformulations in the Prevention and Treatment of Contrast-Induced Nephropathy

Favorite
M1130-06-37 - Micromechanical Thermal Analysis (MTA) to Study Amorphous Relaxations of Small Molecule Drugs

Favorite
T1030-03-18 - Microneedle-Assisted Transdermal Delivery of Optimized Chitosan-Naltrexone Microspheres

Favorite
M0930-03-18 - Microparticles Embedding CaP Nanoparticles for Heart Targeting by Inhalation: Quality by Design Approach for Dry Powder Inhaler Composition

Favorite
W0930-02-11 - Milk Derived Exosomes for Theranostic Applications

Favorite
T1330-07-44 - Miniprintlets: 3D Printed Pellets as a Novel Platform for Multi-drug Therapy

Favorite
T1330-04-23 - Mixed Non-ionic Surfactants Microemulsions with Indomethacin – Structural Studies

Favorite
M1230-06-40 - Mixed-Mode LC-CAD Method Development for the Analysis of Inorganic Ions in Antisense Oligonucleotide (ASO) Drugs

Favorite
T1030-07-46 - Mixture Optimization of Abuse Deterrent Hybrids by Minitab Experimental Design and Analysis

Favorite
M1330-06-38 - Modeling and Prediction of Long-Term Color Change of Tablets Using ASAP and ASAPprime® Software

Favorite
M1030-01-01 - Models for Investigating the Effects of Excipients on Drug Transport

Favorite
W1030-07-47 - Modified In Vitro Release Testing (mIVRT) for Testing of Topical Products

Favorite
M1230-06-42 - Modified In Vitro Release Testing Method for Ophthalmic Suspensions Using Franz Diffusion Cell

Favorite
T1230-04-22 - Molar Mass Matters – Impact of Excipient’s Molecular Weight on Dissolution Performance of Amorphous Solid Dispersions

Favorite
T1130-01-06 - Molecular Structure and Interaction of Amorphous Pharmaceuticals using Solid-state NMR Spectroscopy: A Posaconazole Example

Favorite
M1430-04-23 - Molecular Structure Predicts the Tendency of 6 API to Form Amorphous Solid Dispersions Using Melt-Quenching, Rotary-Evaporation, and Spray-Drying

Favorite
M1330-01-07 - More than 20 years on from Sandimmune® and Neoral®: How would we develop a cyclosporine lipid-based formulation using the tools of today?

Favorite
T1330-07-46 - Multifunctional Magnetic Fe₃O₄ Nanoparticles Coated with Poly(ethylene imine)-Succinic Anhydride Modified with 2,3,5-Triiodobenzoic Acid as CT and MRI Contrast Agents

Favorite
W1230-02-12 - Multifunctional Pathogen-Mimicking Vaccine Delivery System for Influenza Vaccine

Favorite
T1330-02-10 - Naked Poly (Amidoamine) Dendrimers: Anti-Angiogenesis Effects in In-Ovo Chicken Embryo Model

Favorite
M1130-04-27 - Nano Formulation Development using Rotation Revolution Mixer for Toxicological Studies

Favorite
T1330-03-18 - Nanocarrier-Mediated Immunogenic Chemotherapy for Triple Negative Breast Cancer

Favorite
W1230-05-31 - Nanodispersion of Tacrolimus in Rat Pharmacokinetics

Favorite
M1030-01-03 - Nano-in-Micro Powder Technology for the Delivery of Nanoparticles Formulations via the Nose-to-Brain Route

Favorite
M1430-07-45 - Nanoparticle-Mediated Enhanced Delivery of ATRA to Lymph Nodes for Mucosal Vaccination

Favorite
M1330-07-44 - Nanoparticle-Mediated Gene Transfer to the Brain Based on Dual-Functionalized Liposomes

Favorite
T1230-03-19 - Nanoparticles Designed to Deliver Drug(s) across the Blood-Brain Barrier (BBB)

Favorite
T1230-03-17 - Nanoparticles in Smart Hydrogels: A Dual Approach for Targeted Drug Delivery to the Joints

Favorite
W0930-03-16 - Nanosuspension Based Electrolyte Sensitive In Situ Gel for Topical Ocular Delivery of Natamycin

Favorite
W0930-02-12 - Nasal and Intestinal Permeation of Atenolol with Tight Junction Modulator and Fructose Polymer

Favorite
T1530-01-02 - Nateglinide: Three New Polymorphs Discovered by Melt-Crystallization

Favorite
T0930-05-35 - Next Generation of an Oxycodone Immediate Release Product with Abuse Deterrent Features – In Vitro and In Vivo Performance

Favorite
W1230-06-36 - NMR Structure Elucidation and Mechanistic Interpretation of a Novel Rearranged Degradant and Subsequent Use as an Ultra Violet (UV) Relative Response Factor (RRF) Standard

Favorite
W1030-05-35 - Non-destructive Dose Verification of a 3D Printed Anti-hypertensive Polyprintlet

Favorite
M1230-07-43 - Non-destructive Quality Control of 3D Printed Personalized Drug Products for Real-Time Release

Favorite
W1230-01-04 - Non-invasive Three-Dimensional X-Ray Microscopy Imaging Technique for Quantitative Characterization of Lyophilized Drug Product

Favorite
M1530-01-06 - Nose-to-Brain Delivery of Donepezil and Memantine Loaded Liposomes

Favorite
T1530-01-05 - Not Just Polymorphism: The Particle Size as API CQA for Drug Product Development

Favorite
W1130-07-45 - Novel Anti-Counterfeit Measures for 3D Printed Drug Products Using 2D Barcodes and Raman Spectroscopy

Favorite
M1030-03-21 - Novel Application of Hot Melt Extrusion Paired Fused Deposition Modeling 3D Printing Techniques in Fabrication of Ketoprofen Films for Topical Delivery

Favorite
W1030-01-06 - Novel Approaches of Amorphous Solid Dispersion Screening Approaches for APIs with Poor Aqueous Solubility

Favorite
M1230-07-44 - Novel Authentication Technology Using Molecular Tags as a PCID in Solid Oral Dosage Forms

Favorite
M1030-06-36 - Novel Biphasic Lipolysis Testing of Nilotinib Lipid-Based Suspensions to Predict In Vivo Performance

Favorite
T1130-01-07 - Novel Formulation Strategies for Nano-milling in Early Drug Discovery

Favorite
M1230-01-01 - Novel High-Throughput Preformulation Screening Platform for Protein Stability Under Mechanical Stress by Stirring

Favorite
M1030-06-38 - Novel Method for Monitoring of Free Drug Concentration in Presence of Nano-sized Formulations or Dynamically Formed Colloidal Nanoparticles

Favorite
T1230-06-36 - Novel Methodology for Quantitation of Aldehydes in Polyglycols via Oxidation to the Corresponding Carboxylic Acids and Analysis by LC with UV Detection

Favorite
T1330-02-14 - Novel Once-a-Year Controlled Release Capsules for Ruminants

Favorite
M1230-04-25 - Novel Screening Tools for Hot Melt Extrusion: Early Prediction of Formulation Performance

Favorite
M1230-01-03 - Novel Surfactant Excipient Significantly Improves Biologic Stability in Liquid Formulation

Favorite
M1530-06-41 - Nucleic Acid Therapy Purity Methods by Capillary Gel Electrophoresis

Favorite
M1430-06-42 - Observation of API’s Hydration and Dehydration in Formulation Tablets by Frequency- Domain Terahertz Spectroscopy with a High-Peak-Power Tunable Source

Favorite
W1230-05-35 - On-demand 3D Printing of Isoleucine Tablets for the Treatment of MSUD: A Single-Centre, Prospective, Crossover Study

Favorite
T1330-02-08 - On-Demand Versatile Prodrug Nanomicelle for Tumor-Specific Bioimaging and Photothermal-Chemo Synergistic Cancer Therapy

Favorite
T1130-02-12 - One and Two Step IVIVC for Carbamazepine Formulations: Time Scaling through Dissolution Weibull Parameters Scaling

Favorite
M1330-03-19 - Optimization and Characterization of Hot-Melt Extruded Anti-inflammatory and Local Anesthetic Bio-Adhesive Semisolid Formulation Using Design of Experiments (DoE)

Favorite
W0930-07-43 - Optimization of an Evogliptin Active Coating Layer to Prepare Fixed-Dose Combination Tablets for the Treatment of Diabetes

Favorite
T1130-02-10 - Optimization of BCS Class IV Drug Formulation Using Pilot BE Studies Data to Derive In Vivo In Vitro Correlation (IVIVC) Relationship

Favorite
M1530-04-27 - Optimization of BUCHI B-290 Spray-Dryer parameters to enable high-throughput screening of Spray-Dried Solid Dispersions in early stage formulation development.

Favorite
M1030-05-34 - Optimization of Drug X Enteric Coated Mini-tablets Process by Design of Experiment: Influence of Critical Process Parameters (CPP) of GPCG15 on the Physical Characteristics and Release Profile

Favorite
M1330-05-34 - Optimization of Spray-Drying Process Parameters for the Preparation of Levofloxacin/Phytoglycogen/Leucine Dry Powder Inhaler Formulations

Favorite
T1530-01-03 - Optimization of Taste-Masked (-)-Oleocanthal Effervescent Formulation with Potent Activity against HER2-Positive Breast Cancer Growth and Locoregional Recurrence

Favorite
M1530-02-08 - Ovalbumin-Containing Core-Shell Implants Suitable to Obtain a Delayed IgG1 Antibody Response in Mice

Favorite
W1030-02-14 - Overcoming Challenges with Submicron Particle Quantification Using a Combined Approach via Orthogonal Technologies

Favorite
T1230-07-46 - Over-the-Counter (OTC) Male Enhancement Nutraceuticals: Claim, Pharmaceutical Quality, and Safety Assessments

Favorite
T1330-01-06 - Oxaliplatin-Loaded Hydrogel for Prevention of Postoperative Abdominal Adhesion and Colorectal Cancer Therapy

Favorite
T1530-02-11 - Paclitaxel and Letrozole-Loaded Liposomes for the Treatment of Breast Cancer: Formulation Development, Characterization, and Tissue Culture Investigations

Favorite
W0930-03-15 - Paclitaxel Loaded Hydrophobized Gelatin Nanoparticles: Implication of Anacardic Acid Functionalization on Drug Loading and Anti-tumor Efficacy

Favorite
W1230-07-43 - Palatability and Ease of Intake of Fixed-Dose Orally Disintegrating Tablets

Favorite
T1530-05-29 - Patient-Centric Drug Development, Product Design, and Manufacturing: Modular Oral Dosage Forms

Favorite
T1330-03-19 - PEGylated Dendrimer Mediated Delivery of Bortezomib for Improved Anti-cancer Efficacy and In Vivo Pharmacokinetics

Favorite
W0930-06-41 - Performance Evaluation of ASD-Based Tablets: Can Colloid Formation be Modelled?

Favorite
T1330-04-22 - Permeation Enhancement of Transport Media and Their Synergistic Effect with Permeation Enhancer in Nanoemulsions

Favorite
W1130-03-15 - Pharmacokinetic and Pharmacodynamic Evaluation of Multi-Day Topical Application of ∆⁹-Tetrahydrocannabinol-Valine-Hemisuccinate (THC-VHS, NB1111) Nanoemulsion in Normotensive Rabbits

Favorite
T1430-02-13 - Pharmacokinetic and Toxicity Evaluation of Alpinumisoflavone-Loaded Polymeric Micelles

Favorite
W1130-04-25 - Phenylethyl Resorcinol smartLipids – Improved Chemical Stability for Color-Stable Skin Whitening Products

Favorite
T1130-06-41 - Physical and Chemical Stability of Testosterone in Compounded Topical Creams Utilizing a Validated, Stability-Indicating Analytical Method

Favorite
M1530-01-05 - Physical Evaluation of a New Patient-Centered Oral Unit Dosage Form

Favorite
W1230-05-34 - Physical Property Testing of Gelatin and SeaGel® Films for Soft Capsule Applications

Favorite
M1230-02-14 - Physicomechanical Constraints of Components in the Design of Gastroretentive Tablets by Direct Compression

Favorite
M0930-02-09 - Physiologically Based Biopharmaceutics Modeling to Demonstrate Virtual Bioequivalence and Define the Bioequivalence Safe Space: A Case Study

Favorite
M1130-05-30 - Physio-Mechanical Properties of Ultrafine Particle Size Low Molecular Weight Hydroxypropylcellulose: Effect of Binder Particle Size on Tablet Performance

Favorite
M1130-01-05 - Pitfalls and Challenges of Analyzing Particle Size Distribution in Ophthalmic Suspensions Using Laser Diffraction

Favorite
T1430-05-34 - Plasdone^TM Copovidone Ultra S-630 for Oxidation-Labile Drugs

Favorite
M0930-02-11 - PLGA Based Drug Delivery and Importance of In Vitro Release Determination and Experimental Insights: Development of a Novel “Basket-in-Tube” Method

Favorite
M1530-02-10 - Poly(lactic-co-glycolic) Acid Implants for Local Controlled Release of Monoclonal Antibodies, CpG ODN, and Docetaxel

Favorite
M1330-03-17 - Poly(Lactide-co-Glycolide) Based in Situ Film-Forming System for Topical Delivery of Trolamine Salicylate

Favorite
W1130-05-30 - Poly(meth)Acrylate Polymers in FDM 3D Printing as a Platform for Designing Tailored Release Profiles

Favorite
M1530-02-12 - Polyester Dendrimer-Platinum Nanochemotherapeutics: Synthesis and Efficacy in 2D and 3D Lung Cancer In Vitro Models

Favorite
W1130-05-34 - Polymer Influence on the Rheological Properties of Colloidal Microcrystalline Cellulose

Favorite
M1030-02-13 - Polymeric Lipids Nanoparticles: New Approach Utilizing Vitamin E-TPGS And PLGA for Treating Colorectal Cancer

Favorite
T1530-03-20 - Polymeric Nanosystem for Treatment of Ewing’s Sarcoma

Favorite
T1230-01-04 - Polysorbate Degradation in Biologics Formulations and the Formation of FFA Particles

Favorite
T1330-05-33 - Polyvinyl Alcohol (PVA) for Tablet Coating Applications: Enhancing Formulation Flexibility

Favorite
M1030-04-23 - Polyvinyl Alcohol Gel for Topical Delivery of Kinetin

Favorite
T1030-02-09 - Porous 3D Printed 316L Metal Implants Coated with Dexamethasone for Sustained Drug Delivery

Favorite
T0930-04-28 - Posaconazole Cocrystal with Superior Solubility and Dissolution Behavior

Favorite
T1330-07-47 - Positron Emission Tomography-Guided Targeting of Pathogenic E. coli Infections

Favorite
W1130-06-41 - Powerful Combination between AQbD and High-Throughput Analytical Toolkit to Support an Efficient RP-LC Method Development

Favorite
T1430-02-10 - Predicting Density of Amorphous Solid Materials using Molecular Dynamics Simulation

Favorite
T1530-04-23 - Predicting Solid Dispersion Stability Using Multiple Linear Regression Models

Favorite
M1530-04-28 - Predicting the Physical Stability of Amorphous Solid Dispersions: Understanding the Impact of Material Properties

Favorite
M0930-02-10 - Prediction of Fraction of Dose Absorbed Based on In Vitro Solubility and Flux Measurements

Favorite
T1130-02-09 - Prediction of Maximum Absorbable Dose and Fraction Absorbed based on In Vitro Flux Measurements

Favorite
T1030-01-07 - Prediction of Peptide Aggregation Propensities

Favorite
W1030-02-08 - Prediction of the Effect of Co-administration of Food with Granules in Adults and Infants Based on Biorelevant Dissolution Testing

Favorite
W0930-06-38 - Predictive In Vitro Drug Release Testing of Vaginal Dosage Forms - A Novel Method for Establishing an IVIVR for Contraceptive Intravaginal Rings

Favorite
W1030-03-17 - Preparation and Characterization of Hydrophilic Polymer-Lipid Complexes of Phytochemicals Combinations

Favorite
T1430-04-23 - Preparation and Characterization of Lercanidipine Nanoparticles Using High Pressure Homogenizer

Favorite
T1030-04-22 - Preparation and Characterization of Lutein Loaded Nanoparticles Using PLGA-PEG-FOL Polymer

Favorite
W1030-05-33 - Preparation and Optimization of Enteric-Coated Tablet System for Delayed-Release and Solubilization of Bisacodyl

Favorite
T1130-07-43 - Preparation of Triple-Layered Films Using 3D Printing Technology

Favorite
W1230-07-48 - Preparation, Characterization and Performance of Polymeric Particles Encapsulating a Highly Soluble Drug Using Both Batch and Microfluidic Techniques

Favorite
M0930-02-13 - Preparation, Characterization and Pharmacokinetic Study of Donepezil-Loaded PLGA Microparticles Injected in Beagle Model

Favorite
T0930-01-01 - Preparation, Characterization, and Aerosol Performance Testing of Engineered Spray Dried Tobramycin Dry Powder Aerosol Formulations

Favorite
T1430-04-22 - Preparation, Characterization, and Optimization of Pirfenidone-Loaded Polymeric Nanoparticles

Favorite
M1530-04-24 - Preparation, Solid-State Characterization, and Solubility Assessment of Dronedarone HCl-Naringin Co-amorphous Systems

Favorite
W1230-02-10 - Preparation and Evaluation of Transferrin Conjugated Nanostructured Lipid Carriers for Targeting Artemisone to Melanoma Cells

Favorite
W1030-03-20 - Prepartion and Characterization of Gentamicin Sulfate Loaded Inhalable Magnetic Nanoparticles

Favorite
T1530-04-27 - Preventing Crystallization and Improving Dissolution of Delamanid by In Situ Formation of Amorphous Solid Dispersions of Sulfonate Salts

Favorite
T1230-02-14 - Printing Biopharmaceuticals onto Orodispersible Films

Favorite
M0930-06-37 - Product Characterization and Development of In Vitro Drug Release Assay of Exparel® Bupivacaine Multivesicular Liposomes

Favorite
M1230-02-09 - Production of Lysozyme-PLGA Particles for Extended Release Using Hot Melt Extrusion Technology

Favorite
T1030-01-02 - Promoting Intracellular Cholesterol Efflux to Recombinant High-Density Lipoproteins by Cyclodextrins

Favorite
M1030-07-49 - Prospects of Chewable Tablets of Chewing Sticks as an Alternative to Conventional Toothpaste

Favorite
T1230-01-03 - Protection of Proteins from Proteolysis by Lipophilic Complexation

Favorite
W1230-07-45 - Protein Kinase C Inhibitor Anchored BRD4 PROTAC PEGylated Nanoliposomes for the Treatment of BRAFV600E Mutated Vemurafenib-Resistant Melanoma

Favorite
M0930-07-48 - Proteolysis-Targeting Chimeric (PROTAC) Targeting BRD4 Protein: A Novel Potential Therapy for Pancreatic Ductal Adenocarcinoma

Favorite
T1130-05-29 - PVA-Based Sustained Release Matrix Tablets – Roller Compaction vs Direct Compression

Favorite
M1230-05-35 - QbD Approach for Understanding the Effects of Formulation and Process Variables on the Printlets Quality Manufactured by SLS 3D Printing

Favorite
M1530-06-38 - Quality Considerations of the 3D Printable Filaments Manufactured by Continuous Melt Extrusion I: Mechanical Properties Analysis

Favorite
M0930-06-38 - Quality Considerations of the 3D Printed Oral Pharmaceutical Products I: The Effect of Tablet Designs

Favorite
M1530-01-02 - Quality Evaluation of Brand and Generic Extended Release Phenytoin Sodium Capsules

Favorite
T0930-04-26 - Quality-by-Design Guided Engineering of Inhalable Co-amorphous of Itraconazole with Succinic Acid via Spray Drying

Favorite
M1030-06-42 - Quantitative Analysis of Total siRNA in siRNA-Polymeric Nanoparticle Formulation by AEX-HPLC

Favorite
M1130-06-36 - Quantitative Characterization of Crystalline Content in Amorphous Solid Dispersion Formulations Using X-Ray Microscopy

Favorite
T1230-06-42 - Quantitative Comparison of Peptide Impurities in Teriparatide from Biological and Synthetic Origins Using UPLC-MS/MS

Favorite
T1130-05-35 - Quick-Set, High-Solids Pharmaceutical Tablet Coatings

Favorite
T1230-04-28 - Rapid Transition of a Novel Celecoxib Formulation from a Fit-for-Phase Presentation to a Commercializable Product Using an Innovative Integrated Drug Development and Clinical Testing Platform

Favorite
M1330-06-39 - Rapid UPLC-MS/MS Method for Simultaneous Quantification of Kratom Alkaloids in Mitragyna speciosa Products

Favorite
W1130-01-03 - Rational Design and Development of Perfluorocarbon-Based Oxygen Carriers for Organ Preservation

Favorite
M1330-01-01 - Rational Formulation of Ciprofloxacin-Chitosan Nanoplexes for Enhanced In Vitro Drug Release and Extended Synergistic Antimicrobial Potency

Favorite
T1330-01-03 - Ready-to-Use Injectable Formulations Using New Tri-block Copolymers for Anticancer Drug Delivery

Favorite
T1030-07-49 - Release Time and Rate Control Using 3D-Printing Technologies and Evaluation of a Novel Chronotherapeutic Drug Delivery System

Favorite
T1430-03-19 - Remodeling-Tuned Lipoprotein Nanoparticulates Templated for Multidrug Shielding on Sustainable and Combination Therapy of Alzheimer's Disease

Favorite
T1230-07-45 - Repaglinide-Loaded Solid Lipid Nanoparticles for Oral Delivery of Anti-Diabetes Treatment Prepared by Spray Drying and Microfluidization

Favorite
T1330-02-11 - Repurposing an Antimalarial Drug for Efficacy in Diverse Breast Cancer Subtypes

Favorite
T1030-03-20 - Repurposing Artesunate, an Anti-malarial Drug, as an Inhaled Formulation for the Treatment of Pulmonary Arterial Hypertension

Favorite
T0930-06-38 - Residual Solvent Variations in Transdermal Drug Delivery Systems

Favorite
W0930-01-02 - Resveratrol-Loaded Ethosomal In Situ Nasal Gel Drug Delivery: A Novel Approach for Brain Targeting in Glioblastoma

Favorite
M1530-03-19 - Retinoid Containing Face Wash Lotion for the Treatment of Acne [DRL Publication No. 878]

Favorite
W1230-04-24 - Revaprazan-Loaded Surface-Modified Solid Dispersion: Physicochemical Characterization and In Vivo Evaluation in Rats

Favorite
M1130-03-21 - Review of Advanced Analytical Methods in Complex Polymeric Drug Substance Characterization

Favorite
W1030-07-46 - Rheological Characterization of Topical Pharmaceutical Foam Products

Favorite
T1230-05-34 - Rheology Guided Drug Load Optimization in a Plasdone^TM S630 Ultra (Copovidone)/Nifedipine System

Favorite
W1230-07-46 - Rigid Structure Polymers for the Development of Safe and Effective Opioid Drug Formulations

Favorite
T1530-01-06 - Rilpivirine-Associated Aggregation Induced Emission Enables Cell-Based Nanoparticle Tracking

Favorite
T1430-07-44 - RNA Nanoparticles Cooperated with Exosome as Efficient In Vivo RNAi Delivery for Cancer Treatment

Favorite
W1230-03-21 - Root Cause Analysis and Characterization of Foreign Particulate in Parenteral Products Using Multiple Complementary Analytical Techniques

Favorite
M1530-06-37 - RP-HPLC Method Development, Validation, and Determination of Letrozole and Paclitaxel Combination in a Nanoliposome Formulation

Favorite
W1230-07-47 - Safe, Swallowable and Palatable Pediatric Mini-tablet Formulations for a Compound from the WHO Model List of Essential Medicines for Children – Formulation Development and In Vitro Characterization

Favorite
T1530-01-01 - Scalable Manufacturing of Liposomes to Improve Therapeutic Efficacy by Encapsulation of Drugs Using High Pressure Microfluidizer

Favorite
T1230-04-25 - Scaled-Up Production of Lumefantrine Nanoparticles

Favorite
T1130-07-47 - Scientific Networks: Beyond Scientists Engagement, a Hub of Innovation to Boost Operational Excellence

Favorite
T1430-07-48 - Selection of the Suitable Amount of Benzydamine to be Used in a Fixed Combination with Econazole for the Development of a New Vaginal Pessary Formulation

Favorite
M0930-04-28 - Selective Salt and Co-Crystal Generation Using Green Chemomechanical Technology

Favorite
T1030-01-01 - Self-Assembled Biotinylated Nanomicelles Loaded Celecoxib for AMD

Favorite
T0930-07-46 - Self-assembling Lisofylline-Fatty Acid Conjugate for Effective Treatment of Diabetes Mellitus

Favorite
M1330-07-46 - Sensory Evaluation of Norvir® (Ritonavir) 100 mg Powder for Special Populations

Favorite
T1330-07-45 - Shape Memory Expandable Gastroretentive Drug Delivery System Manufactured by 4D Printing

Favorite
W0930-01-07 - Shear Rate Dependent Viscosity as an Indicator of Protein-Protein Interactions and Cluster Formation

Favorite
W1230-05-33 - Silicified Microcrystalline Cellulose for Improving Disintegration Time in Oro-Dispersible Tablets

Favorite
T1530-06-41 - Simplifying Workflows for MAM-Based Critical Quality Attribute Monitoring of Biotherapeutics in Process Development and QC Using a Novel LCMS Platform

Favorite
W0930-04-28 - Simultaneous Improvement of Aqueous Solubility and Tabletability of Theophylline with Cocrystallization

Favorite
T0930-06-37 - Simultaneous UPLC-ESI-MS/MS Analysis of Fourteen Components Including Metabolites of Gumiganghwal-Tang Tablet in Human Plasma: Application to Pharmacokinetic Study

Favorite
M0930-03-17 - Skin Follicular Targeting in Acne Treatment: Potentials with Isotretinoin-Loaded Delonix Nanoparticles

Favorite
M1530-03-16 - Skin Microporation and Iontophoresis for the Rapid Delivery of Ketamine for Treatment-Resistant Depression

Favorite
M1230-04-28 - Small Molecule Nanosuspension Formulation Development Using a Resonant Acoustic Mixer

Favorite
M1130-04-23 - Sodium Oleate-Based Solid Lipid Nanoparticles to Enhance Oral Bioavailability of Oleanolic Acid

Favorite
W1030-04-22 - Solid Self-nanoemulsifying Drug Delivery System (SNEDDS) for Improved Oral Bioavailability of Water-Insoluble Rivaroxaban

Favorite
W1030-01-05 - Solid-State Properties and Manufacturability of Two Celecoxib N-Methyl-2-Pyrrolidone Solvates

Favorite
W1130-07-48 - Solubility Enhancement of Drugs for Colonic Applications Using EUDRAGIT^® FS 100

Favorite
M1130-01-02 - Solubilization of an Insoluble Neural Vasodilator Using a Nanomicelles Drug Delivery System in the Treatment of Subarachnoid Hemorrhage

Favorite
W0930-05-29 - Source Variation of Outer Membranes on Drug Release from Intrauterine Systems

Favorite
M1030-07-43 - Spray Freeze Dried Inhalable Liposomal Powder Formulations for Co-delivery of Synergistic Ciprofloxacin and Colistin Against Multi-drug Resistant Gram-Negative Lung Infections

Favorite
M0930-07-45 - Spray-Dried Engineering of Long-Acting Controlled Release Poly (Lactic-co-Glycolic Acid) Microspheres Loaded with Luteinizing Hormone-Releasing Hormone Agonist (LHRHa)

Favorite
M0930-01-06 - Spray-Drying Versus Spray Freeze-Drying Technique for the Formulation of Inhalable Sildenafil-Citrate Dry Powder

Favorite
M1130-05-31 - Stability of Non-Synthetic Pigments in Fully Formulated Film Coating Systems

Favorite
T1530-07-44 - Stability Studies of Anti-VEGF FpFs Obtained from Bevacizumab Digested with Different Enzymes

Favorite
T1530-04-22 - Stable Amorphous Solid Dispersion Formation is Not Predicted Exclusively by Drug-Polymer Miscibility

Favorite
T1530-01-04 - Standardized and Bias-Corrected Density Functional Theory in the Estimation of X-H Bond Dissociation Energy – Potential Tool in Predicting Oxidative Decomposition of Pharmaceuticals

Favorite
M1130-03-20 - Strategic Analysis of the Roadmap for Implementing Characterization-Based Bioequivalence Approaches in Product-Specific Guidances for Generic Topical Dermatological Drug Products

Favorite
W0930-04-22 - Structure of Molecular Glasses by Synchrotron X-ray Total Scattering

Favorite
T1430-04-28 - Structured Development Approach for Formation of Apremilast Amorphous System and Design of a Controlled Release Drug Delivery System

Favorite
T1130-01-02 - Studies of Solubility and Formulation Methods of Cannabinoid CB₁ Receptor Allosteric Modulator ZCZ011

Favorite
M1230-07-48 - Studies on the Role of Antioxidants in Impurity Profile Control of Rifapentine Tablets

Favorite
T0930-05-33 - Study of the Impact of Wet Granulation Process Parameters on Granule Properties and Compression Characteristics of Poorly Soluble Drug

Favorite
T1230-01-05 - Studying Vesicles Membrane Stability of Nanotransfersomes Containing Bile Salts Using Calcein as a Marker for Stability

Favorite
T1530-06-37 - Submicron Protein Aggregation Measurements for Early Assessment of Formulation Instability

Favorite
M1430-02-10 - Supersaturated Silica-Lipid Hybrid (super-SLH) Oral Drug Delivery Systems: Balancing Drug Loading and In Vivo Performance

Favorite
M1330-04-26 - Surface Characterization as a Tool for Identifying the Factors Affecting the Dissolution Rate of Amorphous Solid Dispersions

Favorite
M1130-01-06 - Surface Properties of Doxil-Mimicking Liposomes: Effect of Composition and Particle Size

Favorite
M1330-04-27 - Surface-Eroding Elastomer Exhibits Zero-Order Release in Highly Loaded LAIs

Favorite
T0930-04-25 - Surfactants as Stabilizers of the Colloidal Phase Formed Upon Amorphous Solid Dispersion Dissolution

Favorite
M1330-03-16 - Susceptibility to Particulate Formation in Parenteral Solutions - A Case Study

Favorite
T1530-07-45 - Sustained Release Floating Tablets Prepared by Fusion Deposition Modeling 3D Printing

Favorite
M1130-02-11 - Sustained-Released Formulation of Nifedipine Solid Dispersion with Various Polymers

Favorite
M1030-05-29 - Synchronized Drug and Polymer Release from Injection Moulded Controlled Release Amorphous Solid Dispersion Tablets

Favorite
M1130-06-39 - Synchrotron X-Ray Diffraction and Pair Distribution Function Analysis of Drug/Polymer Dispersions: A Comparison of Subtraction Techniques to Isolate Intra- and Intermolecular Interactions

Favorite
M0930-03-16 - Synergistic Combination of Novel Tubulin Inhibitor and Dual PI3K/AKT/mTOR-BRD4 Inhibitor to Treat Pancreatic Cancer

Favorite
W1230-03-19 - Synergistic Photothermal/Immunotherapy Modulating Immune Tumor Microenvironment by Core-Shell Gel Microneedles for Melanoma Therapy

Favorite
M1030-03-19 - Synthesis and Characterization of Temozolomide Loaded Albumin Gel as Implantable Formulation for Glioblastoma Treatment

Favorite
T1530-05-33 - Synthesis and Computational Modelling to Predict Loading of 5-fluorouracil into Mesoporous Silica Nanoparticles for the Treatment of Colorectal Cancer

Favorite
M1430-02-08 - Synthetic High-Density Lipoprotein Nanodiscs for Personalized Vaccination against Glioblastoma Multiforme

Favorite
M1430-02-14 - Systematic Development and Optimization of Pirfenidone Liposomes for Non-Small Cell Lung Cancer Treatment

Favorite
W0930-05-31 - Tablet Coatings for Taste-Masking – Efficiency In Vivo

Favorite
M0930-04-27 - Tablet Formulation Development of Amorphous Solid Dispersions with StarTab™ Directly Compressible Starch as Filler

Favorite
T0930-01-06 - Tablet Splitting of Polymeric Matrices

Favorite
M1230-05-34 - Tableting Properties of Direct Compressible Excipients with Different Manufacturing in High-Speed Direct Compression

Favorite
T1030-02-12 - Tacrolimus Nanomicellar Eye Drops as a Topical Treatment for Diabetic Retinopathy

Favorite
T1530-03-18 - Targeted Immunotherapy System using Novel Nanoparticles: Feasibility for Selective Delivery

Favorite
W0930-07-44 - Targeted Knockdown of Pro-inflammatory Cytokines in Adipose Tissue Macrophages and Adipocytes for the Treatment of Insulin Resistance

Favorite
T1530-03-15 - Targeting Specific Immune Cells by Fine Tuning the Physicochemical Properties of Polymeric Nanoparticles

Favorite
W1030-05-30 - Taste Masking Bitter Drugs with Ion Exchange Resin in Carrageenan Based Gummies

Favorite
T1030-03-16 - Taste Masking of Clarithromycin through Microencapsulation in Eugdragit S by Solvent Evaporation Method

Favorite
T1030-05-29 - Taste-Masked Azithromycin Dry Syrup for Pediatric Use Based on EUDRAGIT^® E PO

Favorite
T1030-05-30 - Taste-Masking Effects of Guaifenesin Coated Particles Dependent on Coating Weight Using Hypromellose Phthalate

Favorite
M1030-01-02 - Terconazole Bile Based Nanovesicles: A Novel Platform for Augmented Ocular Delivery

Favorite
W0930-07-47 - Ternary Inclusion Complex of Ebselen with Cyclodextrin Polymer and Soluplus: Targeting Vaginal Candidiasis and Pre-exposure Prophylactic for HIV

Favorite
M1430-01-06 - Texture Analyzer as a CQA Tool to Evaluate Sensorial Properties like Hardness, Adhesiveness, Cohesiveness, Tackiness, Spreadability and Consistency for Topical Ointment Formulation

Favorite
M0930-01-04 - The Aerosol Performance of TNF-α siRNA Solid Lipid Nanoparticles for Potential Pulmonary Delivery

Favorite
W1230-06-42 - The Cloak of Invisibility for Subvisible Particles: Evaluating the Impact of Refractive Index and Color on Measured Particle Count by HIAC and MFI

Favorite
T1130-03-20 - The Correlation of Rheological Behavior and In Vitro Release Rate for 811 Cream

Favorite
W0930-02-13 - The Development of the Hydrogel Based on Sodium Hyaluronate Containing Granisetron

Favorite
M1130-07-46 - The Ease of Orally Taking Mini-tablets Containing a Large Amount of Drug

Favorite
M0930-05-29 - The Effect of Crosslinker Type an